<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><generator>NFE/5.0</generator><title>"아스텔라스" - Google 뉴스</title><link>https://news.google.com/search?cf=all&amp;hl=ko&amp;q=%EC%95%84%EC%8A%A4%ED%85%94%EB%9D%BC%EC%8A%A4&amp;cf=all&amp;gl=KR&amp;ceid=KR:ko</link><language>ko</language><webMaster>news-webmaster@google.com</webMaster><copyright>Copyright © 2026 Google. All rights reserved. This XML feed is made available solely for the purpose of rendering Google News results within a personal feed reader for personal, non-commercial use. Any other use of the feed is expressly prohibited. By accessing this feed or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><lastBuildDate>Sun, 14 Jun 2026 07:05:16 GMT</lastBuildDate><image><title>Google 뉴스</title><url>https://lh3.googleusercontent.com/-DR60l-K8vnyi99NZovm9HlXyZwQ85GMDxiwJWzoasZYCUrPuUM_P_4Rb7ei03j-0nRs0c4F=w256</url><link>https://news.google.com/</link><height>256</height><width>256</width></image><description>Google 뉴스</description><item><title>아스텔라스의 AI 기반 임상 체계 개편과 KRAS 전략이 아스텔라스 파마(TSE:4503) 투자자들에게 미칠 영향 - simplywall.st</title><link>https://news.google.com/rss/articles/CBMitwFBVV95cUxNWWhWUUxGOHJpamRrWjBIVTdPZmJlakx6MVE3dkotUEx4aGhxU0ZoT0I5cG92QUV3Z0d6Q3pfajBXV3VPczVMbGNzcjI1S3NNeVc2aFVCSjJwUjdqMW5VM0tJclhleDgyYjJKbnA0OUk3bGxXaDg2cUhzOE1iOVAxbWxQaGE3TUdnc1phQnUtdm1WWEJsRWluQWQ0ZWRmTTJMcTVram5lSlNaV1R5V0ZxaVNYM1diSVXSAbcBQVVfeXFMTVloVlFMRjhyaWpka1owSFU3T2ZiZWpMejFRN3ZKLVBMeGhocVNGaE9COXBvdkFFd2dHekN6X2owV1d1T3M1TGxjc3IyNUtzTXlXNmhVQkoycFI3ajFuVTNLSXJYZXg4MmIySm5wNDlJN2xsV2g4NnFIczhNYjlQMW1sUGhhN01HZ3NaYUJ1LXZtVlhCbEVpbkFkNGVkZk0yTHE1a2puZUpTWldUeVdGcWlTWDNXYklV?oc=5</link><guid isPermaLink="false">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</guid><pubDate>Sun, 14 Jun 2026 03:07:44 GMT</pubDate><description>&lt;a href="https://news.google.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?oc=5" target="_blank"&gt;아스텔라스의 AI 기반 임상 체계 개편과 KRAS 전략이 아스텔라스 파마(TSE:4503) 투자자들에게 미칠 영향&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;simplywall.st&lt;/font&gt;</description><source url="https://simplywall.st">simplywall.st</source></item><item><title>아스텔라스, 비어와 전립선암 ‘masking TCE’ 17억弗 딜 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE1ldjlzbV9Pb2hNOGpZNXZGRzRGdGM1U2tiUUUyTHBtY2pBUThETndLdFllRUZsbTEya2VGdmE5cmtrenhrT29vb2lYdGNxaFZRUGJVbFRmVQ?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE1ldjlzbV9Pb2hNOGpZNXZGRzRGdGM1U2tiUUUyTHBtY2pBUThETndLdFllRUZsbTEya2VGdmE5cmtrenhrT29vb2lYdGNxaFZRUGJVbFRmVQ</guid><pubDate>Wed, 25 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE1ldjlzbV9Pb2hNOGpZNXZGRzRGdGM1U2tiUUUyTHBtY2pBUThETndLdFllRUZsbTEya2VGdmE5cmtrenhrT29vb2lYdGNxaFZRUGJVbFRmVQ?oc=5" target="_blank"&gt;아스텔라스, 비어와 전립선암 ‘masking TCE’ 17억弗 딜&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>비뇨의학과 처방 1위 아스텔라스···한미약품 신제품으로 추격 - 시사저널e</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE51a0xWWk5KenpxTUJxTWQ2OThBN2ludE9STi0wcWpDX0hQcmJ6ZjV6LXdEaTZ4UkVkOENRMTd5WXFhdzFQM2Jwc1V4OXp3OUk0eVpQRVB6WVluVXFsWEhoUDBpQW51RkxsODlsY2ZqTWN4UdIBdkFVX3lxTE5Ybk5iM29Da2hiSTdieUEzaVdlMGk3c2Jxek5QbWZ4MWdfUW15czRnRXZZSW4yeWM4TDlMQUJSSEJVRFByOEgxSXVmTnlvZzk1NWJqWHEzUHlRUlR2STVwNXAtWktaYm1qS212bjhPZ001cG5tN1E?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE51a0xWWk5KenpxTUJxTWQ2OThBN2ludE9STi0wcWpDX0hQcmJ6ZjV6LXdEaTZ4UkVkOENRMTd5WXFhdzFQM2Jwc1V4OXp3OUk0eVpQRVB6WVluVXFsWEhoUDBpQW51RkxsODlsY2ZqTWN4UdIBdkFVX3lxTE5Ybk5iM29Da2hiSTdieUEzaVdlMGk3c2Jxek5QbWZ4MWdfUW15czRnRXZZSW4yeWM4TDlMQUJSSEJVRFByOEgxSXVmTnlvZzk1NWJqWHEzUHlRUlR2STVwNXAtWktaYm1qS212bjhPZ001cG5tN1E</guid><pubDate>Tue, 24 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE51a0xWWk5KenpxTUJxTWQ2OThBN2ludE9STi0wcWpDX0hQcmJ6ZjV6LXdEaTZ4UkVkOENRMTd5WXFhdzFQM2Jwc1V4OXp3OUk0eVpQRVB6WVluVXFsWEhoUDBpQW51RkxsODlsY2ZqTWN4UdIBdkFVX3lxTE5Ybk5iM29Da2hiSTdieUEzaVdlMGk3c2Jxek5QbWZ4MWdfUW15czRnRXZZSW4yeWM4TDlMQUJSSEJVRFByOEgxSXVmTnlvZzk1NWJqWHEzUHlRUlR2STVwNXAtWktaYm1qS212bjhPZ001cG5tN1E?oc=5" target="_blank"&gt;비뇨의학과 처방 1위 아스텔라스···한미약품 신제품으로 추격&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;시사저널e&lt;/font&gt;</description><source url="https://www.sisajournal-e.com">시사저널e</source></item><item><title>아스텔라스, 美 다이노와 AAV 캡시드 기술도입…근육 타깃 유전자치료 확대 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE4yRGJoT2xwYlBMZ0VnRHdzVkhFMTVoNGxpTnc0VzJrSDhzc19qOUZLajRha1lxaThHa1dzTmdCbU9wNmRESDZ4SFR6TFJOXzVNdVYzVWd6MzJQUDhuM3NqWUFLQ2R4NGl6aVBJUNIBcEFVX3lxTE5yNlJsaGY4bzJwZktJckx6TkhrNW55d1RyZFBraFZIN2FqVGR2N20ybU9Rd3dLcndmS3NZRHloLUs2OGIzNU1GTmZpcGxCczFjVWtZdVVpMzVxUDh4UkQ2V0hqVzQ1STdyV2Raa1ZYQ1o?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE4yRGJoT2xwYlBMZ0VnRHdzVkhFMTVoNGxpTnc0VzJrSDhzc19qOUZLajRha1lxaThHa1dzTmdCbU9wNmRESDZ4SFR6TFJOXzVNdVYzVWd6MzJQUDhuM3NqWUFLQ2R4NGl6aVBJUNIBcEFVX3lxTE5yNlJsaGY4bzJwZktJckx6TkhrNW55d1RyZFBraFZIN2FqVGR2N20ybU9Rd3dLcndmS3NZRHloLUs2OGIzNU1GTmZpcGxCczFjVWtZdVVpMzVxUDh4UkQ2V0hqVzQ1STdyV2Raa1ZYQ1o</guid><pubDate>Thu, 09 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE4yRGJoT2xwYlBMZ0VnRHdzVkhFMTVoNGxpTnc0VzJrSDhzc19qOUZLajRha1lxaThHa1dzTmdCbU9wNmRESDZ4SFR6TFJOXzVNdVYzVWd6MzJQUDhuM3NqWUFLQ2R4NGl6aVBJUNIBcEFVX3lxTE5yNlJsaGY4bzJwZktJckx6TkhrNW55d1RyZFBraFZIN2FqVGR2N20ybU9Rd3dLcndmS3NZRHloLUs2OGIzNU1GTmZpcGxCczFjVWtZdVVpMzVxUDh4UkQ2V0hqVzQ1STdyV2Raa1ZYQ1o?oc=5" target="_blank"&gt;아스텔라스, 美 다이노와 AAV 캡시드 기술도입…근육 타깃 유전자치료 확대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>파드셉 병용 급여화, 아스텔라스 아닌 MSD에 달렸다 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5CR2lqTWNqYnRkNlJPMld1aEpkR0wxSHFkT09HY0x4ZHJJdzNLbDA3REJ0N3RHYWRYejdDcnluZzVXcHhfM1Riel90M180M0VTWHFfV25DZTQyYjJGTWZkRDVyNHhwTnRRSWZz?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5CR2lqTWNqYnRkNlJPMld1aEpkR0wxSHFkT09HY0x4ZHJJdzNLbDA3REJ0N3RHYWRYejdDcnluZzVXcHhfM1Riel90M180M0VTWHFfV25DZTQyYjJGTWZkRDVyNHhwTnRRSWZz</guid><pubDate>Tue, 07 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5CR2lqTWNqYnRkNlJPMld1aEpkR0wxSHFkT09HY0x4ZHJJdzNLbDA3REJ0N3RHYWRYejdDcnluZzVXcHhfM1Riel90M180M0VTWHFfV25DZTQyYjJGTWZkRDVyNHhwTnRRSWZz?oc=5" target="_blank"&gt;파드셉 병용 급여화, 아스텔라스 아닌 MSD에 달렸다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>특허만료 보름 앞두고 '엑스탄디 캡슐제형' 퇴장 수순…제네릭 경쟁 본격화 - 메디팜스투데이</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE1wMUhTWkk1d2xDQ0RaSlAtcGtFRDNRTm9HSXRmVF90QWFjbHF5d2g5X0VkRFowemo1bUxOcndmR2N5VnVfWDJ1a1FmdC1EY2ltQ3dEckloSmpVb0s2dEh3aVZIVlR6RFVF?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE1wMUhTWkk1d2xDQ0RaSlAtcGtFRDNRTm9HSXRmVF90QWFjbHF5d2g5X0VkRFowemo1bUxOcndmR2N5VnVfWDJ1a1FmdC1EY2ltQ3dEckloSmpVb0s2dEh3aVZIVlR6RFVF</guid><pubDate>Thu, 11 Jun 2026 21:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE1wMUhTWkk1d2xDQ0RaSlAtcGtFRDNRTm9HSXRmVF90QWFjbHF5d2g5X0VkRFowemo1bUxOcndmR2N5VnVfWDJ1a1FmdC1EY2ltQ3dEckloSmpVb0s2dEh3aVZIVlR6RFVF?oc=5" target="_blank"&gt;특허만료 보름 앞두고 '엑스탄디 캡슐제형' 퇴장 수순…제네릭 경쟁 본격화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디팜스투데이&lt;/font&gt;</description><source url="https://www.apsk.co.kr">메디팜스투데이</source></item><item><title>엑스탄디 특허 만료 앞둔 아스텔라스…"‘구조적 BD’ 없다" - 약업신문</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE1PLVc4VjB5V3JlVS1tNXpPY2FwcjZqTkVpbW5BeUgwQldkd2FTejZUX1RLbVROWlpLeUVzQjZvVG53bmFFMEtheF9pYnhqSVphdFJnQVM5b0VmTmNIRW1rRDExaFg5dw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE1PLVc4VjB5V3JlVS1tNXpPY2FwcjZqTkVpbW5BeUgwQldkd2FTejZUX1RLbVROWlpLeUVzQjZvVG53bmFFMEtheF9pYnhqSVphdFJnQVM5b0VmTmNIRW1rRDExaFg5dw</guid><pubDate>Mon, 19 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE1PLVc4VjB5V3JlVS1tNXpPY2FwcjZqTkVpbW5BeUgwQldkd2FTejZUX1RLbVROWlpLeUVzQjZvVG53bmFFMEtheF9pYnhqSVphdFJnQVM5b0VmTmNIRW1rRDExaFg5dw?oc=5" target="_blank"&gt;엑스탄디 특허 만료 앞둔 아스텔라스…"‘구조적 BD’ 없다"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>아스텔라스, 한국 신약 스타트업과 손잡았다 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE51ZzVDbHNiVmYyYzJycFljQ1FRNXc4S05MMEdpYmo3dFRxN2NseFlOZnFZNThBVDFBRFROMzFGUDdweVdmMXlGSW5yUVR0T0Q1VEozc1BKNXNyTTl3UWNfSDl5TmJLQzZxNDdYWg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE51ZzVDbHNiVmYyYzJycFljQ1FRNXc4S05MMEdpYmo3dFRxN2NseFlOZnFZNThBVDFBRFROMzFGUDdweVdmMXlGSW5yUVR0T0Q1VEozc1BKNXNyTTl3UWNfSDl5TmJLQzZxNDdYWg</guid><pubDate>Thu, 17 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE51ZzVDbHNiVmYyYzJycFljQ1FRNXc4S05MMEdpYmo3dFRxN2NseFlOZnFZNThBVDFBRFROMzFGUDdweVdmMXlGSW5yUVR0T0Q1VEozc1BKNXNyTTl3UWNfSDl5TmJLQzZxNDdYWg?oc=5" target="_blank"&gt;아스텔라스, 한국 신약 스타트업과 손잡았다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>한국아스텔라스, '엑스탄디정' 보험 급여 출시 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBSN0ZITGFTRWluX09YZFlBZXJqalJGRFpEV3NLSV9Pd0g3THJMcEJfRnRlSHl1NGZHVktjVE02UEpvdEp6YzFHQ0M1VzF6dmFZQ3kxelFEY3JQRVU5d3IzdUJtVE9fVkFxRnk4aw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBSN0ZITGFTRWluX09YZFlBZXJqalJGRFpEV3NLSV9Pd0g3THJMcEJfRnRlSHl1NGZHVktjVE02UEpvdEp6YzFHQ0M1VzF6dmFZQ3kxelFEY3JQRVU5d3IzdUJtVE9fVkFxRnk4aw</guid><pubDate>Thu, 09 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBSN0ZITGFTRWluX09YZFlBZXJqalJGRFpEV3NLSV9Pd0g3THJMcEJfRnRlSHl1NGZHVktjVE02UEpvdEp6YzFHQ0M1VzF6dmFZQ3kxelFEY3JQRVU5d3IzdUJtVE9fVkFxRnk4aw?oc=5" target="_blank"&gt;한국아스텔라스, '엑스탄디정' 보험 급여 출시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>아스텔라스, 'CLDN18.2'+PD-1 삼중 "위암 1차 긍정" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE1XWVRmck1ZYTRKcWhvV2NuZEdWOFh5Ukdlb0wydEtpRlVVX1BDQnNOLUxWcEZaY1B4Ny1IZEs0bXhIMS0xcTVHdWJQV1gwMThOYlN6b2FVQQ?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE1XWVRmck1ZYTRKcWhvV2NuZEdWOFh5Ukdlb0wydEtpRlVVX1BDQnNOLUxWcEZaY1B4Ny1IZEs0bXhIMS0xcTVHdWJQV1gwMThOYlN6b2FVQQ</guid><pubDate>Wed, 14 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE1XWVRmck1ZYTRKcWhvV2NuZEdWOFh5Ukdlb0wydEtpRlVVX1BDQnNOLUxWcEZaY1B4Ny1IZEs0bXhIMS0xcTVHdWJQV1gwMThOYlN6b2FVQQ?oc=5" target="_blank"&gt;아스텔라스, 'CLDN18.2'+PD-1 삼중 "위암 1차 긍정"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>한국아스텔라스, 양성 전립샘비대증 '베솜니' 급여 출시 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5RMzZnSzUyWWZJMFkwTzFzTkxwakpzY1pEMFoxQnBRM0FDdzdSZDFxZDJ1OWc5ejVJNEU3TV95TGdRXzZraXpBS19BeXlRQnlKWjVsdVFPaTNNenl3WU5OcEw1REhnMzJjM2cw?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5RMzZnSzUyWWZJMFkwTzFzTkxwakpzY1pEMFoxQnBRM0FDdzdSZDFxZDJ1OWc5ejVJNEU3TV95TGdRXzZraXpBS19BeXlRQnlKWjVsdVFPaTNNenl3WU5OcEw1REhnMzJjM2cw</guid><pubDate>Thu, 30 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5RMzZnSzUyWWZJMFkwTzFzTkxwakpzY1pEMFoxQnBRM0FDdzdSZDFxZDJ1OWc5ejVJNEU3TV95TGdRXzZraXpBS19BeXlRQnlKWjVsdVFPaTNNenl3WU5OcEw1REhnMzJjM2cw?oc=5" target="_blank"&gt;한국아스텔라스, 양성 전립샘비대증 '베솜니' 급여 출시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>아스텔라스, 다이노 골격근 표적 AAV 캡시드 라이선스 취득 - 의약뉴스</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE03THlJWE44MUs2SDFYWnZjTVdqZFlpRXFMUnVwMWZvcFRtLU5QSmFJQWo0U0pPR1RLYVJWbzlqdjZyREstTWFaWXRyOWluZ2dmaVJscDR5cFA1a0FuSzZhcmZxMUlNMmts?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE03THlJWE44MUs2SDFYWnZjTVdqZFlpRXFMUnVwMWZvcFRtLU5QSmFJQWo0U0pPR1RLYVJWbzlqdjZyREstTWFaWXRyOWluZ2dmaVJscDR5cFA1a0FuSzZhcmZxMUlNMmts</guid><pubDate>Thu, 09 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE03THlJWE44MUs2SDFYWnZjTVdqZFlpRXFMUnVwMWZvcFRtLU5QSmFJQWo0U0pPR1RLYVJWbzlqdjZyREstTWFaWXRyOWluZ2dmaVJscDR5cFA1a0FuSzZhcmZxMUlNMmts?oc=5" target="_blank"&gt;아스텔라스, 다이노 골격근 표적 AAV 캡시드 라이선스 취득&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의약뉴스&lt;/font&gt;</description><source url="https://www.newsmp.com">의약뉴스</source></item><item><title>아스텔라스, 다이노 근육 타깃 ‘AAV캡시드' 옵션행사 - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTFBLQmVlT3AwUmtCcVlJcjR1SUcwZWpVUWJ5QUt3b2Y0dTJfRXdOZ3Z0U2JFS1VVcDZwcXE3eUpvWmRKMGZabUMwbjJscFN2OUlCT0doR005cw?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTFBLQmVlT3AwUmtCcVlJcjR1SUcwZWpVUWJ5QUt3b2Y0dTJfRXdOZ3Z0U2JFS1VVcDZwcXE3eUpvWmRKMGZabUMwbjJscFN2OUlCT0doR005cw</guid><pubDate>Fri, 10 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFBLQmVlT3AwUmtCcVlJcjR1SUcwZWpVUWJ5QUt3b2Y0dTJfRXdOZ3Z0U2JFS1VVcDZwcXE3eUpvWmRKMGZabUMwbjJscFN2OUlCT0doR005cw?oc=5" target="_blank"&gt;아스텔라스, 다이노 근육 타깃 ‘AAV캡시드' 옵션행사&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>아스텔라스, ASCO서 '파드셉' 조기 치료 승부수 던지나 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9qWUtuTm05NjFqbjlSWS1LOWRLWUlmQk91V2NtdjhuSlE0N0lqZzN0UktEdE1ZSC1DZy1mUmpPTm9KV2REajdiTzBvdXplQXQzRHJHTHQ4NDdPNkF5bHlmdk5vbGtzcXJsaG9v?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9qWUtuTm05NjFqbjlSWS1LOWRLWUlmQk91V2NtdjhuSlE0N0lqZzN0UktEdE1ZSC1DZy1mUmpPTm9KV2REajdiTzBvdXplQXQzRHJHTHQ4NDdPNkF5bHlmdk5vbGtzcXJsaG9v</guid><pubDate>Tue, 19 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9qWUtuTm05NjFqbjlSWS1LOWRLWUlmQk91V2NtdjhuSlE0N0lqZzN0UktEdE1ZSC1DZy1mUmpPTm9KV2REajdiTzBvdXplQXQzRHJHTHQ4NDdPNkF5bHlmdk5vbGtzcXJsaG9v?oc=5" target="_blank"&gt;아스텔라스, ASCO서 '파드셉' 조기 치료 승부수 던지나&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>아스텔라스 제약(TSE:4503) 종양 포트폴리오 업데이트 이후 현재 밸류에이션을 다시 살펴봐야 할 때 - simplywall.st</title><link>https://news.google.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?oc=5</link><guid isPermaLink="false">CBMisgFBVV95cUxQdGhQVnBnNGM5ZDlFU29LNVB2azNpaF9iMUhIQnEwdVF2dmlyNEZMcnlYWVZZTzA3cVhTS25nd1o5bGZJUFhFcDFJcG9LSlFvbHVpWkhGQXBBVXZuemFGR3FyamQyU19sbF85MzNuMk5HSjJWOGZTbTdUZXFyU2Q2SV83eENCWUZUdWhSdF9jUEVIODA3d25YLS1vUWtFWWZpY1hDZWpyZVlBbkk5c2xwdm130gG3AUFVX3lxTE8xNTRQdzlnLWRvVklXWGxyRWRFTk9jNnhXcWVzcURXREJVT0trYnJ3amw3cF95Y1ZFRWNXT2tDTDV2dG5CT0lCVWt1NXRSQjF6MVBJbWhLT3h0dU9tSVR5aHZmenByN2Zveml1QXhQWkVqdEc3QVJTWkNfRkZaT2xLOER0TnNGRTJLZFlra2FCekxobjdsREdhbXdtQnRmakNVUUNFeGlqUnM2UGlMbTRsWTBwYkZVRQ</guid><pubDate>Tue, 19 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.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?oc=5" target="_blank"&gt;아스텔라스 제약(TSE:4503) 종양 포트폴리오 업데이트 이후 현재 밸류에이션을 다시 살펴봐야 할 때&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;simplywall.st&lt;/font&gt;</description><source url="https://simplywall.st">simplywall.st</source></item><item><title>아스텔라스, KRAS G12D 'TPD' 1건 "중단"..VHL '선택' - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTFB6XzVqSmpNN0dNbFYyeWtUaEF5MVRZVm13OVBhWl8xcnpXVjJTazltUm14NHg3b3dnQ1lXSm5xbGZxekxmSm1IVVlGNnFpSzNrZjhMYnR3QQ?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTFB6XzVqSmpNN0dNbFYyeWtUaEF5MVRZVm13OVBhWl8xcnpXVjJTazltUm14NHg3b3dnQ1lXSm5xbGZxekxmSm1IVVlGNnFpSzNrZjhMYnR3QQ</guid><pubDate>Wed, 11 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFB6XzVqSmpNN0dNbFYyeWtUaEF5MVRZVm13OVBhWl8xcnpXVjJTazltUm14NHg3b3dnQ1lXSm5xbGZxekxmSm1IVVlGNnFpSzNrZjhMYnR3QQ?oc=5" target="_blank"&gt;아스텔라스, KRAS G12D 'TPD' 1건 "중단"..VHL '선택'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>아스텔라스, 갱년기 치료제 '페졸리네탄트' 日 3상 성공 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE93NmlBaC1oemZpZjRKUFZBSzdncGtVNE8wVE83OUtQM1U0Y1MtNnl4TnZjSFpfeUtMMm1VUHNFMjI0R3FaeW9yWEgxazN4Z3J4bnBMUk9jX00ya1M0TGtWamFHSDluRDdIaGJV?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE93NmlBaC1oemZpZjRKUFZBSzdncGtVNE8wVE83OUtQM1U0Y1MtNnl4TnZjSFpfeUtMMm1VUHNFMjI0R3FaeW9yWEgxazN4Z3J4bnBMUk9jX00ya1M0TGtWamFHSDluRDdIaGJV</guid><pubDate>Tue, 03 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE93NmlBaC1oemZpZjRKUFZBSzdncGtVNE8wVE83OUtQM1U0Y1MtNnl4TnZjSFpfeUtMMm1VUHNFMjI0R3FaeW9yWEgxazN4Z3J4bnBMUk9jX00ya1M0TGtWamFHSDluRDdIaGJV?oc=5" target="_blank"&gt;아스텔라스, 갱년기 치료제 '페졸리네탄트' 日 3상 성공&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>아스텔라스-美 Vir, 전립선암 신약 'VIR-5500' 4800억원 도입 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9VNDQ5a2drYzUzZUhYQ3RPY1l3N1pJM1BFQW5yVXFnX0VCVXZVczdkWHlJRmRnaktIZVZJNE1kVWstYl9Sa3dZcFNOdWg0aXc5dHVpVUhzdUV3STlFS2Z4YWlWeUdxanowcFZF?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9VNDQ5a2drYzUzZUhYQ3RPY1l3N1pJM1BFQW5yVXFnX0VCVXZVczdkWHlJRmRnaktIZVZJNE1kVWstYl9Sa3dZcFNOdWg0aXc5dHVpVUhzdUV3STlFS2Z4YWlWeUdxanowcFZF</guid><pubDate>Tue, 24 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9VNDQ5a2drYzUzZUhYQ3RPY1l3N1pJM1BFQW5yVXFnX0VCVXZVczdkWHlJRmRnaktIZVZJNE1kVWstYl9Sa3dZcFNOdWg0aXc5dHVpVUhzdUV3STlFS2Z4YWlWeUdxanowcFZF?oc=5" target="_blank"&gt;아스텔라스-美 Vir, 전립선암 신약 'VIR-5500' 4800억원 도입&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>아스텔라스제약 '빌로이주100.300mg' 등 4개사 4품목, 약평위 급여 적정 심사 벽 뚫어 - 데일리메디팜</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE02b011cEFteGZWVWUwbm5RdWZWT1FTUVE2eWI2Ny10MnpnbE9xYUQ5dWZhWTdwRU9XYnZtUXFQMWxTQWJ4MWFMTlg3Q1RNN2dSajA1RkFGNXk4REdldlFpMlR4QlIwa3pSNWptVW9R?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE02b011cEFteGZWVWUwbm5RdWZWT1FTUVE2eWI2Ny10MnpnbE9xYUQ5dWZhWTdwRU9XYnZtUXFQMWxTQWJ4MWFMTlg3Q1RNN2dSajA1RkFGNXk4REdldlFpMlR4QlIwa3pSNWptVW9R</guid><pubDate>Thu, 04 Jun 2026 22:44:26 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE02b011cEFteGZWVWUwbm5RdWZWT1FTUVE2eWI2Ny10MnpnbE9xYUQ5dWZhWTdwRU9XYnZtUXFQMWxTQWJ4MWFMTlg3Q1RNN2dSajA1RkFGNXk4REdldlFpMlR4QlIwa3pSNWptVW9R?oc=5" target="_blank"&gt;아스텔라스제약 '빌로이주100.300mg' 등 4개사 4품목, 약평위 급여 적정 심사 벽 뚫어&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리메디팜&lt;/font&gt;</description><source url="http://m.dailymedipharm.com">데일리메디팜</source></item><item><title>한국아스텔라스, 전립선암 치료제 '엑스탄디정' 급여 출시 - 청년의사</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE9QZm9pQ295VHlxZTFETUo0Qk9RV2d4V0lkVE9JX3JFZ2ZBTk12NXZvZW50VURsNXhHb1BobVhzN0g5ZWp1Qmh2SHFnRVlhTGZsQmZqYXNEdm1WQmppZjFtWUJqS2J0bXpNOWl0a1F5NNIBc0FVX3lxTE1sLWJTXzhWaG9jSjl5WXdQLWY4QkxUUTlCcTVlWW9OMjM1NmZUTUUtMFJ2TGZDMGdZNVZXZVMtUHVaYzhudDNaX3ByVnJGUFNfUmJxMVBFTXN0V3dBdjFKWGtDYkZ0RmVBY0VTX2Y1Yzdlcm8?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE9QZm9pQ295VHlxZTFETUo0Qk9RV2d4V0lkVE9JX3JFZ2ZBTk12NXZvZW50VURsNXhHb1BobVhzN0g5ZWp1Qmh2SHFnRVlhTGZsQmZqYXNEdm1WQmppZjFtWUJqS2J0bXpNOWl0a1F5NNIBc0FVX3lxTE1sLWJTXzhWaG9jSjl5WXdQLWY4QkxUUTlCcTVlWW9OMjM1NmZUTUUtMFJ2TGZDMGdZNVZXZVMtUHVaYzhudDNaX3ByVnJGUFNfUmJxMVBFTXN0V3dBdjFKWGtDYkZ0RmVBY0VTX2Y1Yzdlcm8</guid><pubDate>Fri, 10 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE9QZm9pQ295VHlxZTFETUo0Qk9RV2d4V0lkVE9JX3JFZ2ZBTk12NXZvZW50VURsNXhHb1BobVhzN0g5ZWp1Qmh2SHFnRVlhTGZsQmZqYXNEdm1WQmppZjFtWUJqS2J0bXpNOWl0a1F5NNIBc0FVX3lxTE1sLWJTXzhWaG9jSjl5WXdQLWY4QkxUUTlCcTVlWW9OMjM1NmZUTUUtMFJ2TGZDMGdZNVZXZVMtUHVaYzhudDNaX3ByVnJGUFNfUmJxMVBFTXN0V3dBdjFKWGtDYkZ0RmVBY0VTX2Y1Yzdlcm8?oc=5" target="_blank"&gt;한국아스텔라스, 전립선암 치료제 '엑스탄디정' 급여 출시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;청년의사&lt;/font&gt;</description><source url="http://www.docdocdoc.co.kr">청년의사</source></item><item><title>한국아스텔라스, 신임 MA 총괄에 백소영 상무 영입 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE03aUlSNzJtLTk3VmFnZ3BncjNMUEpuSC1mNVRTNDR0cUdOWjJhcTRmUi15U0NORk5PbV83N0xJVTU2RUZ3NjJiT2wzVWMzTWNMMXhtZzNEMHJvUlBIa3dhb243bzZSQnlkd2tB?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE03aUlSNzJtLTk3VmFnZ3BncjNMUEpuSC1mNVRTNDR0cUdOWjJhcTRmUi15U0NORk5PbV83N0xJVTU2RUZ3NjJiT2wzVWMzTWNMMXhtZzNEMHJvUlBIa3dhb243bzZSQnlkd2tB</guid><pubDate>Tue, 01 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE03aUlSNzJtLTk3VmFnZ3BncjNMUEpuSC1mNVRTNDR0cUdOWjJhcTRmUi15U0NORk5PbV83N0xJVTU2RUZ3NjJiT2wzVWMzTWNMMXhtZzNEMHJvUlBIa3dhb243bzZSQnlkd2tB?oc=5" target="_blank"&gt;한국아스텔라스, 신임 MA 총괄에 백소영 상무 영입&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>'엑스탄디' 특허만료 임박…아스텔라스, 후속 신약개발 속도 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTE1keGxLMnJON2tBS2lVaXBydkFhNE5LV0JpcmIxZTZyWHN5VUdEclNSeGh5cFZ5bzN5SHlmWXBCVENHNVU3N0tMZlJ1a29vMTJidjJPc1p3?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTE1keGxLMnJON2tBS2lVaXBydkFhNE5LV0JpcmIxZTZyWHN5VUdEclNSeGh5cFZ5bzN5SHlmWXBCVENHNVU3N0tMZlJ1a29vMTJidjJPc1p3</guid><pubDate>Tue, 10 Mar 2026 07:09:06 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE1keGxLMnJON2tBS2lVaXBydkFhNE5LV0JpcmIxZTZyWHN5VUdEclNSeGh5cFZ5bzN5SHlmWXBCVENHNVU3N0tMZlJ1a29vMTJidjJPc1p3?oc=5" target="_blank"&gt;'엑스탄디' 특허만료 임박…아스텔라스, 후속 신약개발 속도&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>한국아스텔라스 전이성 위암 표적치료제 빌로이① - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE91RV9uMUVVNWpYUTdvR0dJXy1QYjZmWG96QmhMR0VISm1hNENscEIxU1FGbW4yMWtpeEFLQzNGN3JVbnBWMWU3N0tNU3JvSEtiM2lSSGtrdE5kUXhnWmpGMU1tREpJbXZoTEE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE91RV9uMUVVNWpYUTdvR0dJXy1QYjZmWG96QmhMR0VISm1hNENscEIxU1FGbW4yMWtpeEFLQzNGN3JVbnBWMWU3N0tNU3JvSEtiM2lSSGtrdE5kUXhnWmpGMU1tREpJbXZoTEE</guid><pubDate>Mon, 30 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE91RV9uMUVVNWpYUTdvR0dJXy1QYjZmWG96QmhMR0VISm1hNENscEIxU1FGbW4yMWtpeEFLQzNGN3JVbnBWMWU3N0tNU3JvSEtiM2lSSGtrdE5kUXhnWmpGMU1tREpJbXZoTEE?oc=5" target="_blank"&gt;한국아스텔라스 전이성 위암 표적치료제 빌로이①&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>아스텔라스, 지도형 위축 치료제 ‘아이저베이’ 中 허가 심사 돌입 - 메디코파마</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE5wUXdGLXNZVW52Rm5VYmo0MW9rbFM5U25SS0c5QlFIWDdITnRLel9FbGppYVJpQUxEd1E3MkVoTC1QRWF2OVlSeUtuMkNocEZ4c1pPY0NqQW9zN1BTUHVlMGNQY3FXbV82MC1ZaEtZRW9lUQ?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE5wUXdGLXNZVW52Rm5VYmo0MW9rbFM5U25SS0c5QlFIWDdITnRLel9FbGppYVJpQUxEd1E3MkVoTC1QRWF2OVlSeUtuMkNocEZ4c1pPY0NqQW9zN1BTUHVlMGNQY3FXbV82MC1ZaEtZRW9lUQ</guid><pubDate>Tue, 19 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE5wUXdGLXNZVW52Rm5VYmo0MW9rbFM5U25SS0c5QlFIWDdITnRLel9FbGppYVJpQUxEd1E3MkVoTC1QRWF2OVlSeUtuMkNocEZ4c1pPY0NqQW9zN1BTUHVlMGNQY3FXbV82MC1ZaEtZRW9lUQ?oc=5" target="_blank"&gt;아스텔라스, 지도형 위축 치료제 ‘아이저베이’ 中 허가 심사 돌입&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디코파마&lt;/font&gt;</description><source url="https://www.medicopharma.co.kr">메디코파마</source></item><item><title>한국아스텔라스 전이성 요로상피암 치료제 파드셉(下) - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE8xY3YtUEk5MnZXN0tGb3pybU1QQTBjbzhCLVBmNC1ROHR1ZS04SU5Vb1hUSFp2X2pmcjQxS3pQTkY3M3pleTRYZnhhdjJUYXpqTjc4X1FTTThnV0N0d1VwN2hiVmZxRXRkckE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE8xY3YtUEk5MnZXN0tGb3pybU1QQTBjbzhCLVBmNC1ROHR1ZS04SU5Vb1hUSFp2X2pmcjQxS3pQTkY3M3pleTRYZnhhdjJUYXpqTjc4X1FTTThnV0N0d1VwN2hiVmZxRXRkckE</guid><pubDate>Wed, 20 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE8xY3YtUEk5MnZXN0tGb3pybU1QQTBjbzhCLVBmNC1ROHR1ZS04SU5Vb1hUSFp2X2pmcjQxS3pQTkY3M3pleTRYZnhhdjJUYXpqTjc4X1FTTThnV0N0d1VwN2hiVmZxRXRkckE?oc=5" target="_blank"&gt;한국아스텔라스 전이성 요로상피암 치료제 파드셉(下)&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>아스텔라스, ‘베솜니서방정’ - 메디포뉴스</title><link>https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5lOEFSdWhzcHotSDhvTUlITUJnNl9GV3ZhSkExSF9yeGQya1NoT3lBX1F1bXAxR1lrVUdPbHJYS1BLaXp2a240WXlYU2lvM3B6Y193TmNnOUhRR09wbWU1dTFnXzZ3Yms?oc=5</link><guid isPermaLink="false">CBMiZ0FVX3lxTE5lOEFSdWhzcHotSDhvTUlITUJnNl9GV3ZhSkExSF9yeGQya1NoT3lBX1F1bXAxR1lrVUdPbHJYS1BLaXp2a240WXlYU2lvM3B6Y193TmNnOUhRR09wbWU1dTFnXzZ3Yms</guid><pubDate>Thu, 30 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5lOEFSdWhzcHotSDhvTUlITUJnNl9GV3ZhSkExSF9yeGQya1NoT3lBX1F1bXAxR1lrVUdPbHJYS1BLaXp2a240WXlYU2lvM3B6Y193TmNnOUhRR09wbWU1dTFnXzZ3Yms?oc=5" target="_blank"&gt;아스텔라스, ‘베솜니서방정’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디포뉴스&lt;/font&gt;</description><source url="https://www.medifonews.com">메디포뉴스</source></item><item><title>화이자·아스텔라스, ‘파드셉+키트루다SC’ MIBC 대상 美 sBLA 우선심사 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5LdnVaNnRtSkpCV2NkX2kxSkNFR3hGM2xlNmROWlY4LXY5RjBZWXVOaUh3VlR2aWswd2RzMEVnR3VGR0hTRU5jalY2ZmZxTWtMSXB3R3AtS25FaXdnYUFGQmFUOHpZNEJxSUNKMNIBcEFVX3lxTE1FV2lfbW1ld09VUFZfV2tXbGI1VWVrcUxGVUllcmRmVmE3TklvM1ZQbnAyREs3d1cxWUM1N29wYzZYR1VmcURVN0c2VFpOQWRIcGx2QjZXT0luN3dmRnJxSDZqak9hOEtTQU81ejYtQTU?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5LdnVaNnRtSkpCV2NkX2kxSkNFR3hGM2xlNmROWlY4LXY5RjBZWXVOaUh3VlR2aWswd2RzMEVnR3VGR0hTRU5jalY2ZmZxTWtMSXB3R3AtS25FaXdnYUFGQmFUOHpZNEJxSUNKMNIBcEFVX3lxTE1FV2lfbW1ld09VUFZfV2tXbGI1VWVrcUxGVUllcmRmVmE3TklvM1ZQbnAyREs3d1cxWUM1N29wYzZYR1VmcURVN0c2VFpOQWRIcGx2QjZXT0luN3dmRnJxSDZqak9hOEtTQU81ejYtQTU</guid><pubDate>Tue, 21 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5LdnVaNnRtSkpCV2NkX2kxSkNFR3hGM2xlNmROWlY4LXY5RjBZWXVOaUh3VlR2aWswd2RzMEVnR3VGR0hTRU5jalY2ZmZxTWtMSXB3R3AtS25FaXdnYUFGQmFUOHpZNEJxSUNKMNIBcEFVX3lxTE1FV2lfbW1ld09VUFZfV2tXbGI1VWVrcUxGVUllcmRmVmE3TklvM1ZQbnAyREs3d1cxWUM1N29wYzZYR1VmcURVN0c2VFpOQWRIcGx2QjZXT0luN3dmRnJxSDZqak9hOEtTQU81ejYtQTU?oc=5" target="_blank"&gt;화이자·아스텔라스, ‘파드셉+키트루다SC’ MIBC 대상 美 sBLA 우선심사&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>[기획] ⑭“파이프라인보다 ‘선별 능력’에 베팅”… 아스텔라스, ‘성공 설계자’로의 진화 - 금융경제플러스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5WRTBYR0EwVzRXRm00aHdra1g3Zk1NY3lMRWdxUmk1SWxyLVdVRVBQY3RDdmY4ZGdtS1UtZ3dDMzZUbkVoazJDZmIxWkZLcWR6YnN1SXdscDl4eTctanNtRk1LZTVUTUpkWWhOdg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5WRTBYR0EwVzRXRm00aHdra1g3Zk1NY3lMRWdxUmk1SWxyLVdVRVBQY3RDdmY4ZGdtS1UtZ3dDMzZUbkVoazJDZmIxWkZLcWR6YnN1SXdscDl4eTctanNtRk1LZTVUTUpkWWhOdg</guid><pubDate>Tue, 03 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5WRTBYR0EwVzRXRm00aHdra1g3Zk1NY3lMRWdxUmk1SWxyLVdVRVBQY3RDdmY4ZGdtS1UtZ3dDMzZUbkVoazJDZmIxWkZLcWR6YnN1SXdscDl4eTctanNtRk1LZTVUTUpkWWhOdg?oc=5" target="_blank"&gt;[기획] ⑭“파이프라인보다 ‘선별 능력’에 베팅”… 아스텔라스, ‘성공 설계자’로의 진화&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;금융경제플러스&lt;/font&gt;</description><source url="https://www.kndaily.co.kr">금융경제플러스</source></item><item><title>한국아스텔라스, 전립선암 치료제 ‘엑스탄디정’ 건강보험 급여 출시 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9tWmxKR3FhOUdGN1dxaWxsMmlVYkUxbHhCV2I2MkpCU1VtWG9PMDdoNEVjZW1vS2FINlBCN0kwTWxINVNpbDhhT0JkZC13ZWhBVDdqSXFXM2l0WnZTZUpyLTkwdXI3MkVDd2RSctIBcEFVX3lxTFAybHZfYWVNenNFbTJaZ2RxNldKckd0Nl9hRkx2dURYc2JMM2JuMjRUYUYtWmdEVmdyMWFMYkV5cTBQNW1EUWMwdEFlNWhYa1gwRW9aTFdMNVctRERsYWtaaDlEUXh5NHRWeEdET0dwWms?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9tWmxKR3FhOUdGN1dxaWxsMmlVYkUxbHhCV2I2MkpCU1VtWG9PMDdoNEVjZW1vS2FINlBCN0kwTWxINVNpbDhhT0JkZC13ZWhBVDdqSXFXM2l0WnZTZUpyLTkwdXI3MkVDd2RSctIBcEFVX3lxTFAybHZfYWVNenNFbTJaZ2RxNldKckd0Nl9hRkx2dURYc2JMM2JuMjRUYUYtWmdEVmdyMWFMYkV5cTBQNW1EUWMwdEFlNWhYa1gwRW9aTFdMNVctRERsYWtaaDlEUXh5NHRWeEdET0dwWms</guid><pubDate>Thu, 09 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9tWmxKR3FhOUdGN1dxaWxsMmlVYkUxbHhCV2I2MkpCU1VtWG9PMDdoNEVjZW1vS2FINlBCN0kwTWxINVNpbDhhT0JkZC13ZWhBVDdqSXFXM2l0WnZTZUpyLTkwdXI3MkVDd2RSctIBcEFVX3lxTFAybHZfYWVNenNFbTJaZ2RxNldKckd0Nl9hRkx2dURYc2JMM2JuMjRUYUYtWmdEVmdyMWFMYkV5cTBQNW1EUWMwdEFlNWhYa1gwRW9aTFdMNVctRERsYWtaaDlEUXh5NHRWeEdET0dwWms?oc=5" target="_blank"&gt;한국아스텔라스, 전립선암 치료제 ‘엑스탄디정’ 건강보험 급여 출시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>아스텔라스 '전격 수용' 승부수… 파드셉 병용 약가협상 주목 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTFBmYTNFVXZNbGxZSWRCREZ2RjlmREtIN0hQOFNrNk5hQmVBQnBZTFliRFlZb3pETTd6M2FJNHdrMDRnZWsyck0xYzc3LTc2TTlXT0htNUVydk1HSXVxOVZuSS02V1puX2hkb2luOFhGd1BEOGM?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTFBmYTNFVXZNbGxZSWRCREZ2RjlmREtIN0hQOFNrNk5hQmVBQnBZTFliRFlZb3pETTd6M2FJNHdrMDRnZWsyck0xYzc3LTc2TTlXT0htNUVydk1HSXVxOVZuSS02V1puX2hkb2luOFhGd1BEOGM</guid><pubDate>Mon, 20 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFBmYTNFVXZNbGxZSWRCREZ2RjlmREtIN0hQOFNrNk5hQmVBQnBZTFliRFlZb3pETTd6M2FJNHdrMDRnZWsyck0xYzc3LTc2TTlXT0htNUVydk1HSXVxOVZuSS02V1puX2hkb2luOFhGd1BEOGM?oc=5" target="_blank"&gt;아스텔라스 '전격 수용' 승부수… 파드셉 병용 약가협상 주목&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>[이엠디] 한국아스텔라스, 복용 편의성 개선한 ‘베솜니서방정’ 출시… 장기 치료 환자들의 증상 및 삶의 질 개선 동시 공략 - eMD Medical News</title><link>https://news.google.com/rss/articles/CBMiW0FVX3lxTFBobG9fWDFPbkYwbkpabG5NdnBRcVd0Zk14ODFIUldGMTFUeElvVVdiM1U5SEo2aHJSMnN6VW1paXV3Q2xWOWFmbEVneGtOYmxidWkzX3UxbTRmT3M?oc=5</link><guid isPermaLink="false">CBMiW0FVX3lxTFBobG9fWDFPbkYwbkpabG5NdnBRcVd0Zk14ODFIUldGMTFUeElvVVdiM1U5SEo2aHJSMnN6VW1paXV3Q2xWOWFmbEVneGtOYmxidWkzX3UxbTRmT3M</guid><pubDate>Thu, 30 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTFBobG9fWDFPbkYwbkpabG5NdnBRcVd0Zk14ODFIUldGMTFUeElvVVdiM1U5SEo2aHJSMnN6VW1paXV3Q2xWOWFmbEVneGtOYmxidWkzX3UxbTRmT3M?oc=5" target="_blank"&gt;[이엠디] 한국아스텔라스, 복용 편의성 개선한 ‘베솜니서방정’ 출시… 장기 치료 환자들의 증상 및 삶의 질 개선 동시 공략&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;eMD Medical News&lt;/font&gt;</description><source url="https://mdon.co.kr">eMD Medical News</source></item><item><title>한국아스텔라스 전이성 위암 표적치료제 빌로이③ - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBhRDg4VmN2RHVkNjFuNUxBRnJQOUllaEFfbEI0WEtqTmxpRUN4SnF6Qk8zc0lFa3NvQWZBcW9sTFBFU1pucW41azFjYWR4eHBIck14aUxmazhKS0NZUUEwN2dXNlVBWFNUc0E?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBhRDg4VmN2RHVkNjFuNUxBRnJQOUllaEFfbEI0WEtqTmxpRUN4SnF6Qk8zc0lFa3NvQWZBcW9sTFBFU1pucW41azFjYWR4eHBIck14aUxmazhKS0NZUUEwN2dXNlVBWFNUc0E</guid><pubDate>Mon, 13 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBhRDg4VmN2RHVkNjFuNUxBRnJQOUllaEFfbEI0WEtqTmxpRUN4SnF6Qk8zc0lFa3NvQWZBcW9sTFBFU1pucW41azFjYWR4eHBIck14aUxmazhKS0NZUUEwN2dXNlVBWFNUc0E?oc=5" target="_blank"&gt;한국아스텔라스 전이성 위암 표적치료제 빌로이③&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>아스텔라스, 美 다이노테라퓨틱스 AI 설계 ‘근육 표적 AAV 캡시드’ 확보 … 유전자치료제 전달 한계 돌파 시도 - 헬스오</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE16VVRROE94aGQtY1ZSZHFoTXl1WmFfVXB0UVd0cTZrd1dwN2RnZkc3TzZGSWphN1lEX3pEVTRBNEJYdEl1dkpkNkg5OUhyZ1c0dWZhMVY0YzJKQQ?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE16VVRROE94aGQtY1ZSZHFoTXl1WmFfVXB0UVd0cTZrd1dwN2RnZkc3TzZGSWphN1lEX3pEVTRBNEJYdEl1dkpkNkg5OUhyZ1c0dWZhMVY0YzJKQQ</guid><pubDate>Fri, 10 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE16VVRROE94aGQtY1ZSZHFoTXl1WmFfVXB0UVd0cTZrd1dwN2RnZkc3TzZGSWphN1lEX3pEVTRBNEJYdEl1dkpkNkg5OUhyZ1c0dWZhMVY0YzJKQQ?oc=5" target="_blank"&gt;아스텔라스, 美 다이노테라퓨틱스 AI 설계 ‘근육 표적 AAV 캡시드’ 확보 … 유전자치료제 전달 한계 돌파 시도&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스오&lt;/font&gt;</description><source url="https://healtho.co.kr">헬스오</source></item><item><title>아스텔라스 제약 주가, 오늘 하락하는 이유는? - Investing.com 한국어</title><link>https://news.google.com/rss/articles/CBMid0FVX3lxTFB6Z3ppU2NGWlhjLUZPcUYwc282SmFfdkhEWWtWUlVyTXdtM3NMX00xWFo0UVFtd0RrSWJhUmdEa2RVY2NBcU5ISTAtVjVEOEJPSlh2djVnQzJMLUwwb2xkMnhoeDUwU1hEY1VCWWhDR1lBYi1ORjk0?oc=5</link><guid isPermaLink="false">CBMid0FVX3lxTFB6Z3ppU2NGWlhjLUZPcUYwc282SmFfdkhEWWtWUlVyTXdtM3NMX00xWFo0UVFtd0RrSWJhUmdEa2RVY2NBcU5ISTAtVjVEOEJPSlh2djVnQzJMLUwwb2xkMnhoeDUwU1hEY1VCWWhDR1lBYi1ORjk0</guid><pubDate>Tue, 26 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFB6Z3ppU2NGWlhjLUZPcUYwc282SmFfdkhEWWtWUlVyTXdtM3NMX00xWFo0UVFtd0RrSWJhUmdEa2RVY2NBcU5ISTAtVjVEOEJPSlh2djVnQzJMLUwwb2xkMnhoeDUwU1hEY1VCWWhDR1lBYi1ORjk0?oc=5" target="_blank"&gt;아스텔라스 제약 주가, 오늘 하락하는 이유는?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Investing.com 한국어&lt;/font&gt;</description><source url="https://kr.investing.com">Investing.com 한국어</source></item><item><title>아스텔라스, 근육질환 타깃 AAV 캡시드 도입…다이노와 협력 확대 - 메디코파마</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE1hNmxRQzdic0JyTVpWSV9ubEszd25PTmN2ZWhiRTVRMDBsMTU3V3hRV0V6MXZsb3duNUlNa0JTOTlfajg1c21uZVRiUk5HZHZIX0s0QUtlRHhOMVNnM3pwT2RhT2NsMFVEZl9YbDJ2dXplUQ?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE1hNmxRQzdic0JyTVpWSV9ubEszd25PTmN2ZWhiRTVRMDBsMTU3V3hRV0V6MXZsb3duNUlNa0JTOTlfajg1c21uZVRiUk5HZHZIX0s0QUtlRHhOMVNnM3pwT2RhT2NsMFVEZl9YbDJ2dXplUQ</guid><pubDate>Thu, 09 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE1hNmxRQzdic0JyTVpWSV9ubEszd25PTmN2ZWhiRTVRMDBsMTU3V3hRV0V6MXZsb3duNUlNa0JTOTlfajg1c21uZVRiUk5HZHZIX0s0QUtlRHhOMVNnM3pwT2RhT2NsMFVEZl9YbDJ2dXplUQ?oc=5" target="_blank"&gt;아스텔라스, 근육질환 타깃 AAV 캡시드 도입…다이노와 협력 확대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디코파마&lt;/font&gt;</description><source url="https://www.medicopharma.co.kr">메디코파마</source></item><item><title>"파드셉 위해서라면…" 공격적 행보 이어가는 아스텔라스 - 메디칼타임즈</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE1TbEcyRmVGLVpwUlQ1WHhfelJYckxnQUt5LWdTejE4RVNEOC1rbnlIaE5WRThOb0tQWWpfLXN3cTBSZm93b0RaOXY4UlQ1aXYyLVNvQ0pFVDQzYVlITl92UUhuZEs2bUtFd0RHQm1GVUgxZw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE1TbEcyRmVGLVpwUlQ1WHhfelJYckxnQUt5LWdTejE4RVNEOC1rbnlIaE5WRThOb0tQWWpfLXN3cTBSZm93b0RaOXY4UlQ1aXYyLVNvQ0pFVDQzYVlITl92UUhuZEs2bUtFd0RHQm1GVUgxZw</guid><pubDate>Mon, 18 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE1TbEcyRmVGLVpwUlQ1WHhfelJYckxnQUt5LWdTejE4RVNEOC1rbnlIaE5WRThOb0tQWWpfLXN3cTBSZm93b0RaOXY4UlQ1aXYyLVNvQ0pFVDQzYVlITl92UUhuZEs2bUtFd0RHQm1GVUgxZw?oc=5" target="_blank"&gt;"파드셉 위해서라면…" 공격적 행보 이어가는 아스텔라스&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디칼타임즈&lt;/font&gt;</description><source url="https://www.medicaltimes.com">메디칼타임즈</source></item><item><title>아스텔라스, ‘보체 C5 억제제’ 아이저베이 中 NDA 접수…GA 치료 확대 기대 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE1HUy1PNWs2ZUk5NmhEeFlTSVVMVEE1aU9PR1dJLUk1cEdrRjN0a3dwX2VBbmF6VjRhMF9FUUtHRl9Wck52ZDdjNVl4bzloUGFqcEIyNWdhWGZfNTFJX3BEWmR2OFlraW9Idks2WtIBcEFVX3lxTE5rODRuNkE3UFJPQUllcW1NUHhYdU1fNHUzQTdnbG9FejJha1daeUV4OTFybm82VFpPdFNIalpIYzdBQ0F0d1UwOWZCdnZyRE5Uclk0RWVYcDhIVlBRUEhIRkp5RlVIVDk1djZwWGV4LVE?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE1HUy1PNWs2ZUk5NmhEeFlTSVVMVEE1aU9PR1dJLUk1cEdrRjN0a3dwX2VBbmF6VjRhMF9FUUtHRl9Wck52ZDdjNVl4bzloUGFqcEIyNWdhWGZfNTFJX3BEWmR2OFlraW9Idks2WtIBcEFVX3lxTE5rODRuNkE3UFJPQUllcW1NUHhYdU1fNHUzQTdnbG9FejJha1daeUV4OTFybm82VFpPdFNIalpIYzdBQ0F0d1UwOWZCdnZyRE5Uclk0RWVYcDhIVlBRUEhIRkp5RlVIVDk1djZwWGV4LVE</guid><pubDate>Mon, 18 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1HUy1PNWs2ZUk5NmhEeFlTSVVMVEE1aU9PR1dJLUk1cEdrRjN0a3dwX2VBbmF6VjRhMF9FUUtHRl9Wck52ZDdjNVl4bzloUGFqcEIyNWdhWGZfNTFJX3BEWmR2OFlraW9Idks2WtIBcEFVX3lxTE5rODRuNkE3UFJPQUllcW1NUHhYdU1fNHUzQTdnbG9FejJha1daeUV4OTFybm82VFpPdFNIalpIYzdBQ0F0d1UwOWZCdnZyRE5Uclk0RWVYcDhIVlBRUEhIRkp5RlVIVDk1djZwWGV4LVE?oc=5" target="_blank"&gt;아스텔라스, ‘보체 C5 억제제’ 아이저베이 中 NDA 접수…GA 치료 확대 기대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>한국아스텔라스, 전립선암 치료제 '엑스탄디정' 보험 급여 출시 - MEDI:GATE NEWS</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE5kVnhxQWtkbUV5NUVpdVpVTUpWYXI1MWpiaGVWZFF5cDFmZ0hJWS1jaWk4cWZKY0d5NzFueXlWblAtXzBDLUMwZGZWLVJ3c1k5cmRSQg?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE5kVnhxQWtkbUV5NUVpdVpVTUpWYXI1MWpiaGVWZFF5cDFmZ0hJWS1jaWk4cWZKY0d5NzFueXlWblAtXzBDLUMwZGZWLVJ3c1k5cmRSQg</guid><pubDate>Fri, 10 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE5kVnhxQWtkbUV5NUVpdVpVTUpWYXI1MWpiaGVWZFF5cDFmZ0hJWS1jaWk4cWZKY0d5NzFueXlWblAtXzBDLUMwZGZWLVJ3c1k5cmRSQg?oc=5" target="_blank"&gt;한국아스텔라스, 전립선암 치료제 '엑스탄디정' 보험 급여 출시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MEDI:GATE NEWS&lt;/font&gt;</description><source url="https://m.medigatenews.com">MEDI:GATE NEWS</source></item><item><title>日 제약사 아스텔라스의 2픽... '티큐브잇' '아바타테라퓨틱스' - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFB2MDQ2YlpJOWZCTnEyYTJpUUxyWVhyNkZuMl93N1dmemxkdVV4c09Dc3VOVnlDRTM3NWpCRV9FWTNaQUhFQ0t1YUdrcm5XelpVMkJodUJfRHNuLUljTVNVODhydzNOR0NHRUE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFB2MDQ2YlpJOWZCTnEyYTJpUUxyWVhyNkZuMl93N1dmemxkdVV4c09Dc3VOVnlDRTM3NWpCRV9FWTNaQUhFQ0t1YUdrcm5XelpVMkJodUJfRHNuLUljTVNVODhydzNOR0NHRUE</guid><pubDate>Thu, 24 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFB2MDQ2YlpJOWZCTnEyYTJpUUxyWVhyNkZuMl93N1dmemxkdVV4c09Dc3VOVnlDRTM3NWpCRV9FWTNaQUhFQ0t1YUdrcm5XelpVMkJodUJfRHNuLUljTVNVODhydzNOR0NHRUE?oc=5" target="_blank"&gt;日 제약사 아스텔라스의 2픽... '티큐브잇' '아바타테라퓨틱스'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>‘완전한 유연근무제’, 한국아스텔라스의 매력을 더욱 높이다 [건강한겨레] - 한겨레</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTFBaRThGeW8zMHJlTXhrQ2dfRmNaVzgyc2ZiOGxqT0JQVDI4blFFQzR2Vnd4bGRoSGlIeE02dGZqZ1dEQ0VKdnRYN0dQMWI1QkZ0S21UQWowUzlPMXhfTXdFVFMtZ01FQXo1?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTFBaRThGeW8zMHJlTXhrQ2dfRmNaVzgyc2ZiOGxqT0JQVDI4blFFQzR2Vnd4bGRoSGlIeE02dGZqZ1dEQ0VKdnRYN0dQMWI1QkZ0S21UQWowUzlPMXhfTXdFVFMtZ01FQXo1</guid><pubDate>Mon, 21 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTFBaRThGeW8zMHJlTXhrQ2dfRmNaVzgyc2ZiOGxqT0JQVDI4blFFQzR2Vnd4bGRoSGlIeE02dGZqZ1dEQ0VKdnRYN0dQMWI1QkZ0S21UQWowUzlPMXhfTXdFVFMtZ01FQXo1?oc=5" target="_blank"&gt;‘완전한 유연근무제’, 한국아스텔라스의 매력을 더욱 높이다 [건강한겨레]&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한겨레&lt;/font&gt;</description><source url="https://www.hani.co.kr">한겨레</source></item><item><title>아스텔라스-MSD, '키트루다+파드셉' 급여두고 온도차, 왜? - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE1BMXhlQmhTbTRqczBhNUhlLWpKdlE0U1M0MGlCZE5heEdvUk1XRm9mRC1fcGQtblRoRnJDZXRCZnJWRVFwbmY1ZzVvT2IzUDdRVk5Nc0VXeWZFQ3FNTlZoRHBGaWhMZnVoSThF?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE1BMXhlQmhTbTRqczBhNUhlLWpKdlE0U1M0MGlCZE5heEdvUk1XRm9mRC1fcGQtblRoRnJDZXRCZnJWRVFwbmY1ZzVvT2IzUDdRVk5Nc0VXeWZFQ3FNTlZoRHBGaWhMZnVoSThF</guid><pubDate>Tue, 15 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1BMXhlQmhTbTRqczBhNUhlLWpKdlE0U1M0MGlCZE5heEdvUk1XRm9mRC1fcGQtblRoRnJDZXRCZnJWRVFwbmY1ZzVvT2IzUDdRVk5Nc0VXeWZFQ3FNTlZoRHBGaWhMZnVoSThF?oc=5" target="_blank"&gt;아스텔라스-MSD, '키트루다+파드셉' 급여두고 온도차, 왜?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>한국아스텔라스, '빌로이' 출시국 전문의 대상 마스터클래스 진행 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9DbXZsTm4tZVczdVUzMHJWcDBsYVpFY1o0SFR0M1lSRFhxUmtoQzYzWmpaa0hwOEVqSVRKLTBpU3J4WDdkUHE1SXJJc2Jxa1hYcVhaRHV6emRWSkFubk5SZ3plMWpWVGVjWE5F?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9DbXZsTm4tZVczdVUzMHJWcDBsYVpFY1o0SFR0M1lSRFhxUmtoQzYzWmpaa0hwOEVqSVRKLTBpU3J4WDdkUHE1SXJJc2Jxa1hYcVhaRHV6emRWSkFubk5SZ3plMWpWVGVjWE5F</guid><pubDate>Thu, 04 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9DbXZsTm4tZVczdVUzMHJWcDBsYVpFY1o0SFR0M1lSRFhxUmtoQzYzWmpaa0hwOEVqSVRKLTBpU3J4WDdkUHE1SXJJc2Jxa1hYcVhaRHV6emRWSkFubk5SZ3plMWpWVGVjWE5F?oc=5" target="_blank"&gt;한국아스텔라스, '빌로이' 출시국 전문의 대상 마스터클래스 진행&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>아스텔라스, 'CLDN18.2' 췌장암 1차 2상 "OS개선 실패" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE9xQlV5aUE2RjZDclhqbzBXbGVlV3hvTVRRZWlGTmFjakZncElJNW9YLXdJN1N4ZXJkZXVHdjVDa3V5U3huNC1UTXRaa1FnU2ZfS3lFNDBFaw?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE9xQlV5aUE2RjZDclhqbzBXbGVlV3hvTVRRZWlGTmFjakZncElJNW9YLXdJN1N4ZXJkZXVHdjVDa3V5U3huNC1UTXRaa1FnU2ZfS3lFNDBFaw</guid><pubDate>Wed, 15 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE9xQlV5aUE2RjZDclhqbzBXbGVlV3hvTVRRZWlGTmFjakZncElJNW9YLXdJN1N4ZXJkZXVHdjVDa3V5U3huNC1UTXRaa1FnU2ZfS3lFNDBFaw?oc=5" target="_blank"&gt;아스텔라스, 'CLDN18.2' 췌장암 1차 2상 "OS개선 실패"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>한국아스텔라스 이선희 전무, 이집트 지사 사장 영전 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFAycWJyMEpmWGZsQ01BUldnS3dIdHBUS3MxLU52NjFKWHAtR2Q1bTBIOG5zQWpqNFVCTHVtR0tCXzdKMzZWLTRhdEU2cWJLSW1BN3hqampfWEZ1OHgzM2R5NGZXeWdTcG04VkdF?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFAycWJyMEpmWGZsQ01BUldnS3dIdHBUS3MxLU52NjFKWHAtR2Q1bTBIOG5zQWpqNFVCTHVtR0tCXzdKMzZWLTRhdEU2cWJLSW1BN3hqampfWEZ1OHgzM2R5NGZXeWdTcG04VkdF</guid><pubDate>Mon, 21 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFAycWJyMEpmWGZsQ01BUldnS3dIdHBUS3MxLU52NjFKWHAtR2Q1bTBIOG5zQWpqNFVCTHVtR0tCXzdKMzZWLTRhdEU2cWJLSW1BN3hqampfWEZ1OHgzM2R5NGZXeWdTcG04VkdF?oc=5" target="_blank"&gt;한국아스텔라스 이선희 전무, 이집트 지사 사장 영전&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>한국아스텔라스제약 '엑스탄디정80밀리그램'·대웅제약 '펙수클루정40밀리그램' 등 약가유연계약 적용 약제 '종근당 '에소듀오미니정10/350밀리그램'·안국약품 '에이두타연질캡슐0.5밀리그램' 등 약제 급여 신설'…유한양행 '티로랙스캡슐'·한국다케다제약 '텍타정40밀 - 메디컬헤럴드</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5qLXM4MEdnM0Fabm1Sc2Iwd0lrTDhfZjE4MzJMQmlCZmExWTF0U0hyZUoyVzFzZGQ4NlhtZVVOekp4UE5GZXBHX1hKT1RnLW9MeFJrTnZvMDFBVGVfVlRwRG1Qc2pta3FBdzlz0gFvQVVfeXFMTXVfSjlHVDdJeFAtOEdCXzhlWXUwbzJ1cExGMTRpRXk1cnprbkplY2c5Y2xBTFVUWHprVXFtcE8wYjAxMXJfS2RDRnIzM3V2MDRCTlRUc1hTdlZIaWk5anJyeHFKSWRXay1SelBkbURj?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5qLXM4MEdnM0Fabm1Sc2Iwd0lrTDhfZjE4MzJMQmlCZmExWTF0U0hyZUoyVzFzZGQ4NlhtZVVOekp4UE5GZXBHX1hKT1RnLW9MeFJrTnZvMDFBVGVfVlRwRG1Qc2pta3FBdzlz0gFvQVVfeXFMTXVfSjlHVDdJeFAtOEdCXzhlWXUwbzJ1cExGMTRpRXk1cnprbkplY2c5Y2xBTFVUWHprVXFtcE8wYjAxMXJfS2RDRnIzM3V2MDRCTlRUc1hTdlZIaWk5anJyeHFKSWRXay1SelBkbURj</guid><pubDate>Mon, 01 Jun 2026 23:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5qLXM4MEdnM0Fabm1Sc2Iwd0lrTDhfZjE4MzJMQmlCZmExWTF0U0hyZUoyVzFzZGQ4NlhtZVVOekp4UE5GZXBHX1hKT1RnLW9MeFJrTnZvMDFBVGVfVlRwRG1Qc2pta3FBdzlz0gFvQVVfeXFMTXVfSjlHVDdJeFAtOEdCXzhlWXUwbzJ1cExGMTRpRXk1cnprbkplY2c5Y2xBTFVUWHprVXFtcE8wYjAxMXJfS2RDRnIzM3V2MDRCTlRUc1hTdlZIaWk5anJyeHFKSWRXay1SelBkbURj?oc=5" target="_blank"&gt;한국아스텔라스제약 '엑스탄디정80밀리그램'·대웅제약 '펙수클루정40밀리그램' 등 약가유연계약 적용 약제 '종근당 '에소듀오미니정10/350밀리그램'·안국약품 '에이두타연질캡슐0.5밀리그램' 등 약제 급여 신설'…유한양행 '티로랙스캡슐'·한국다케다제약 '텍타정40밀&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디컬헤럴드&lt;/font&gt;</description><source url="http://www.mediherald.com">메디컬헤럴드</source></item><item><title>한국아스텔라스 전이성 위암 표적치료제 빌로이 ④ - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBUV0RkOVlBcDMtUkY3SV9wRC1jdDJ4OWVsbjRhcmRySmdhdkxGeDNSdW42RUM5NkEzLVdYQVZNOEZnYTFEcWZHUXc0TW9sMHZGMXNhbXBuOWpBWXFKM3l3dG9vR0tkbVpNM0E?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBUV0RkOVlBcDMtUkY3SV9wRC1jdDJ4OWVsbjRhcmRySmdhdkxGeDNSdW42RUM5NkEzLVdYQVZNOEZnYTFEcWZHUXc0TW9sMHZGMXNhbXBuOWpBWXFKM3l3dG9vR0tkbVpNM0E</guid><pubDate>Mon, 20 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBUV0RkOVlBcDMtUkY3SV9wRC1jdDJ4OWVsbjRhcmRySmdhdkxGeDNSdW42RUM5NkEzLVdYQVZNOEZnYTFEcWZHUXc0TW9sMHZGMXNhbXBuOWpBWXFKM3l3dG9vR0tkbVpNM0E?oc=5" target="_blank"&gt;한국아스텔라스 전이성 위암 표적치료제 빌로이 ④&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>특허 무력화된 ‘엑스탄디’…한국아스텔라스제약, 제형 변경으로 점유율 수성 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE53c1pPNGRrd3N1bW45eHBkQzVuaFl6Yy1SOFVLVUJZWTlWSWxaRkFHbTJ6YTYya1J3VW40YktTX0Uta0RvV1hOdVYyclZkcEdiT3FDQjhYUzFBLWd3WG91dHRKclRSNmxWM1JjbtIBcEFVX3lxTE12SUZKNUN4SHFBX18xT01RdlR6eG9NdnJOWVBsZTZSNElBcjVUdHZBTGRrb2FYamY4bGlLTXcxc04tWHB3YW5tWFdkaDI3a2c4ZFB4SFVqclZZbFFBUTdoNFFRem1zV2VOd3A5UHNkNF8?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE53c1pPNGRrd3N1bW45eHBkQzVuaFl6Yy1SOFVLVUJZWTlWSWxaRkFHbTJ6YTYya1J3VW40YktTX0Uta0RvV1hOdVYyclZkcEdiT3FDQjhYUzFBLWd3WG91dHRKclRSNmxWM1JjbtIBcEFVX3lxTE12SUZKNUN4SHFBX18xT01RdlR6eG9NdnJOWVBsZTZSNElBcjVUdHZBTGRrb2FYamY4bGlLTXcxc04tWHB3YW5tWFdkaDI3a2c4ZFB4SFVqclZZbFFBUTdoNFFRem1zV2VOd3A5UHNkNF8</guid><pubDate>Mon, 13 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE53c1pPNGRrd3N1bW45eHBkQzVuaFl6Yy1SOFVLVUJZWTlWSWxaRkFHbTJ6YTYya1J3VW40YktTX0Uta0RvV1hOdVYyclZkcEdiT3FDQjhYUzFBLWd3WG91dHRKclRSNmxWM1JjbtIBcEFVX3lxTE12SUZKNUN4SHFBX18xT01RdlR6eG9NdnJOWVBsZTZSNElBcjVUdHZBTGRrb2FYamY4bGlLTXcxc04tWHB3YW5tWFdkaDI3a2c4ZFB4SFVqclZZbFFBUTdoNFFRem1zV2VOd3A5UHNkNF8?oc=5" target="_blank"&gt;특허 무력화된 ‘엑스탄디’…한국아스텔라스제약, 제형 변경으로 점유율 수성&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>엑스탄디 제네릭, 6월 특허만료 대격전 예고…지엘파마 가세 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiUEFVX3lxTFBEdXQ1aDZBU2pzQy1mcmhwcV81dkRLeEJqMHU1S3I0dENkeFA2Zno1dkV2MHdUb3NlNUY0aE9uandodWtNY0R3MlpiN1E2ODg4?oc=5</link><guid isPermaLink="false">CBMiUEFVX3lxTFBEdXQ1aDZBU2pzQy1mcmhwcV81dkRLeEJqMHU1S3I0dENkeFA2Zno1dkV2MHdUb3NlNUY0aE9uandodWtNY0R3MlpiN1E2ODg4</guid><pubDate>Tue, 21 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFBEdXQ1aDZBU2pzQy1mcmhwcV81dkRLeEJqMHU1S3I0dENkeFA2Zno1dkV2MHdUb3NlNUY0aE9uandodWtNY0R3MlpiN1E2ODg4?oc=5" target="_blank"&gt;엑스탄디 제네릭, 6월 특허만료 대격전 예고…지엘파마 가세&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>아스텔라스, 인도 루핀·자이더스와 '미르베트릭' 특허 분쟁 합의 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9PYTl0eU9WUFFLcURaTmp6SHRLUEVhZzEzQkoyRlI5dUhEenJMMzVxQ21ELXIwNDBzVzlKMi1weGxJZDM3b0JXbGxESFhQUlhaWjRHQUt6cFdRLXF1LVJGZlB4emFtYm5LazAw?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9PYTl0eU9WUFFLcURaTmp6SHRLUEVhZzEzQkoyRlI5dUhEenJMMzVxQ21ELXIwNDBzVzlKMi1weGxJZDM3b0JXbGxESFhQUlhaWjRHQUt6cFdRLXF1LVJGZlB4emFtYm5LazAw</guid><pubDate>Thu, 12 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9PYTl0eU9WUFFLcURaTmp6SHRLUEVhZzEzQkoyRlI5dUhEenJMMzVxQ21ELXIwNDBzVzlKMi1weGxJZDM3b0JXbGxESFhQUlhaWjRHQUt6cFdRLXF1LVJGZlB4emFtYm5LazAw?oc=5" target="_blank"&gt;아스텔라스, 인도 루핀·자이더스와 '미르베트릭' 특허 분쟁 합의&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>한국아스텔라스 클라우딘18.2 양성 전이성 위암 표적치료제 빌로이 ② - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE8tMkJLNG5mbS1obkRXV19NbFQ2ZlZTSTFUN2Z2RHJJWUdwZjd6OGJTZlg0cmtRcGl3NF82NzNlbmRqcTZGV2VDRzlTWXFsS1F2RVFwQTB6bTZtZGZGYkY1dTJuTEV4eE9QeEE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE8tMkJLNG5mbS1obkRXV19NbFQ2ZlZTSTFUN2Z2RHJJWUdwZjd6OGJTZlg0cmtRcGl3NF82NzNlbmRqcTZGV2VDRzlTWXFsS1F2RVFwQTB6bTZtZGZGYkY1dTJuTEV4eE9QeEE</guid><pubDate>Mon, 06 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE8tMkJLNG5mbS1obkRXV19NbFQ2ZlZTSTFUN2Z2RHJJWUdwZjd6OGJTZlg0cmtRcGl3NF82NzNlbmRqcTZGV2VDRzlTWXFsS1F2RVFwQTB6bTZtZGZGYkY1dTJuTEV4eE9QeEE?oc=5" target="_blank"&gt;한국아스텔라스 클라우딘18.2 양성 전이성 위암 표적치료제 빌로이 ②&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>아스텔라스, 버社 전립선암 치료물질 전략적 제휴 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBHbmpZSF81NmdzWUVkSHBqYk54dUFPR0ZKdVhrMGNRck9zNWJ3ODhYN09Sd0o5T0VNWGFRTzIyQ19aVUNiZUptQnhnQ08zc1pSclZlRzZPakZUdTNvOTVkdVRQcXRya1NST1Fj?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBHbmpZSF81NmdzWUVkSHBqYk54dUFPR0ZKdVhrMGNRck9zNWJ3ODhYN09Sd0o5T0VNWGFRTzIyQ19aVUNiZUptQnhnQ08zc1pSclZlRzZPakZUdTNvOTVkdVRQcXRya1NST1Fj</guid><pubDate>Tue, 24 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBHbmpZSF81NmdzWUVkSHBqYk54dUFPR0ZKdVhrMGNRck9zNWJ3ODhYN09Sd0o5T0VNWGFRTzIyQ19aVUNiZUptQnhnQ08zc1pSclZlRzZPakZUdTNvOTVkdVRQcXRya1NST1Fj?oc=5" target="_blank"&gt;아스텔라스, 버社 전립선암 치료물질 전략적 제휴&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>아스텔라스, 로봇 세포배양 시스템 '마호로' 美 첨단기술 지정돼 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9nMXNzck12VU13Vlk3STFTQTU0MHRWakxIUDk1cFBsY01FVGJXX1hSZG84dk1fcnZ3T2N0TnJHWWQyZHFYd0pKb3hZQkxHUDhGY0wxQU9EdHhUaEhDZkplVjBVMEtsbTRXUlpN?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9nMXNzck12VU13Vlk3STFTQTU0MHRWakxIUDk1cFBsY01FVGJXX1hSZG84dk1fcnZ3T2N0TnJHWWQyZHFYd0pKb3hZQkxHUDhGY0wxQU9EdHhUaEhDZkplVjBVMEtsbTRXUlpN</guid><pubDate>Thu, 18 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9nMXNzck12VU13Vlk3STFTQTU0MHRWakxIUDk1cFBsY01FVGJXX1hSZG84dk1fcnZ3T2N0TnJHWWQyZHFYd0pKb3hZQkxHUDhGY0wxQU9EdHhUaEhDZkplVjBVMEtsbTRXUlpN?oc=5" target="_blank"&gt;아스텔라스, 로봇 세포배양 시스템 '마호로' 美 첨단기술 지정돼&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>한국아스텔라스, 전이성 요로상피암 치료제 파드셉(上) - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE1jdDZUaHdxMlZLSXVtY1NFYmhUNjROMEsydXdZSFBSX2hOQXhvUWRQdDRXQjdjckFnalNWTW9seHJUX0V5d0dILThJMU5hMzhNeENHcm44VEg2LTdLaVFJRk1rZjhwQ0JZamc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE1jdDZUaHdxMlZLSXVtY1NFYmhUNjROMEsydXdZSFBSX2hOQXhvUWRQdDRXQjdjckFnalNWTW9seHJUX0V5d0dILThJMU5hMzhNeENHcm44VEg2LTdLaVFJRk1rZjhwQ0JZamc</guid><pubDate>Wed, 06 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE1jdDZUaHdxMlZLSXVtY1NFYmhUNjROMEsydXdZSFBSX2hOQXhvUWRQdDRXQjdjckFnalNWTW9seHJUX0V5d0dILThJMU5hMzhNeENHcm44VEg2LTdLaVFJRk1rZjhwQ0JZamc?oc=5" target="_blank"&gt;한국아스텔라스, 전이성 요로상피암 치료제 파드셉(上)&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>아스텔라스 제약, 2025 회계연도 3분기 실적 발표: 매출 10% 증가, 핵심 이익 49% 급증 - Investing.com 한국어</title><link>https://news.google.com/rss/articles/CBMicEFVX3lxTE81dURMZjV4V2pnMENkc2RlMTdNWWxjbl9UTC1ha0UweGZWakduQUtrZzB1cEhaMnMyNXVqelljSUJMWUc4ZEdXUXJiSEM1NnN0OUVrSWRlcC0zZnhVMG1WZ2tqNzY5MUhubXVnQ3JFbEI?oc=5</link><guid isPermaLink="false">CBMicEFVX3lxTE81dURMZjV4V2pnMENkc2RlMTdNWWxjbl9UTC1ha0UweGZWakduQUtrZzB1cEhaMnMyNXVqelljSUJMWUc4ZEdXUXJiSEM1NnN0OUVrSWRlcC0zZnhVMG1WZ2tqNzY5MUhubXVnQ3JFbEI</guid><pubDate>Thu, 05 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE81dURMZjV4V2pnMENkc2RlMTdNWWxjbl9UTC1ha0UweGZWakduQUtrZzB1cEhaMnMyNXVqelljSUJMWUc4ZEdXUXJiSEM1NnN0OUVrSWRlcC0zZnhVMG1WZ2tqNzY5MUhubXVnQ3JFbEI?oc=5" target="_blank"&gt;아스텔라스 제약, 2025 회계연도 3분기 실적 발표: 매출 10% 증가, 핵심 이익 49% 급증&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Investing.com 한국어&lt;/font&gt;</description><source url="https://kr.investing.com">Investing.com 한국어</source></item><item><title>아스텔라스 ‘조스파타’, FLT3 변이 AML 1차 치료제 도전 ‘고배’… 표준 치료와 대등한 효과 확인 - 금융경제플러스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFA1UUdOSHM4b3c0Z3ZLdW13d3JaVW5iY211ajc1RE91NjBwdEhRY25neUJrSW5qcDdYdWJUTzFBWEJhNjg1Q1pNUUNWUU1nZ0RzTzBNYTk3Skc4d3BsNTNjMEtTSFYyeW1OYUpBcg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFA1UUdOSHM4b3c0Z3ZLdW13d3JaVW5iY211ajc1RE91NjBwdEhRY25neUJrSW5qcDdYdWJUTzFBWEJhNjg1Q1pNUUNWUU1nZ0RzTzBNYTk3Skc4d3BsNTNjMEtTSFYyeW1OYUpBcg</guid><pubDate>Tue, 10 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFA1UUdOSHM4b3c0Z3ZLdW13d3JaVW5iY211ajc1RE91NjBwdEhRY25neUJrSW5qcDdYdWJUTzFBWEJhNjg1Q1pNUUNWUU1nZ0RzTzBNYTk3Skc4d3BsNTNjMEtTSFYyeW1OYUpBcg?oc=5" target="_blank"&gt;아스텔라스 ‘조스파타’, FLT3 변이 AML 1차 치료제 도전 ‘고배’… 표준 치료와 대등한 효과 확인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;금융경제플러스&lt;/font&gt;</description><source url="https://www.kndaily.co.kr">금융경제플러스</source></item><item><title>아스텔라스, '파드셉'으로 신약 간 병용 급여 물꼬 틀까 - 청년의사</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE42Yk1kUnVjdi1UeTdRcnRTM0kzSUJNeGl6TkJNSG85dWg5MU8xTVVvTFR0NFJ6cGJZSm1YUHctTGF1eGk1eDBTUjUxTnVHQmxkeE9LY3FTUFhmRmg1dklfTTBiUjl3SFE0dVRsZHBORdIBc0FVX3lxTE52WjBvaUNaZXQ4OEJnYjZNa2tCdFhOMFBVUUQ5M1V3RnY2MVZXNkpEc2MwRVVwZzJJR2RSaWdXOVhwNGJ2b2xrZEJQVDdyZ1N2TURvcEZwb0VqZ05EMFZTYW5tTDRlSkVrZlZhMUVlQ0VaMmM?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE42Yk1kUnVjdi1UeTdRcnRTM0kzSUJNeGl6TkJNSG85dWg5MU8xTVVvTFR0NFJ6cGJZSm1YUHctTGF1eGk1eDBTUjUxTnVHQmxkeE9LY3FTUFhmRmg1dklfTTBiUjl3SFE0dVRsZHBORdIBc0FVX3lxTE52WjBvaUNaZXQ4OEJnYjZNa2tCdFhOMFBVUUQ5M1V3RnY2MVZXNkpEc2MwRVVwZzJJR2RSaWdXOVhwNGJ2b2xrZEJQVDdyZ1N2TURvcEZwb0VqZ05EMFZTYW5tTDRlSkVrZlZhMUVlQ0VaMmM</guid><pubDate>Tue, 19 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE42Yk1kUnVjdi1UeTdRcnRTM0kzSUJNeGl6TkJNSG85dWg5MU8xTVVvTFR0NFJ6cGJZSm1YUHctTGF1eGk1eDBTUjUxTnVHQmxkeE9LY3FTUFhmRmg1dklfTTBiUjl3SFE0dVRsZHBORdIBc0FVX3lxTE52WjBvaUNaZXQ4OEJnYjZNa2tCdFhOMFBVUUQ5M1V3RnY2MVZXNkpEc2MwRVVwZzJJR2RSaWdXOVhwNGJ2b2xrZEJQVDdyZ1N2TURvcEZwb0VqZ05EMFZTYW5tTDRlSkVrZlZhMUVlQ0VaMmM?oc=5" target="_blank"&gt;아스텔라스, '파드셉'으로 신약 간 병용 급여 물꼬 틀까&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;청년의사&lt;/font&gt;</description><source url="http://www.docdocdoc.co.kr">청년의사</source></item><item><title>아스텔라스는 '파·키·일·병' 구하기에 성공할 수 있을까 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFB2NE94ckxsd09xa0FUR3YtbktsMXVyd3lVSlVMd0tNdkx0S0FPOFU0am4tUjNyc09hTlZSeGdEVjNKeE8xQUQtdEJaWlJKUEJJSHEtWExTT1l1dWJQOVZmT29vVVlGREREY0xYZw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFB2NE94ckxsd09xa0FUR3YtbktsMXVyd3lVSlVMd0tNdkx0S0FPOFU0am4tUjNyc09hTlZSeGdEVjNKeE8xQUQtdEJaWlJKUEJJSHEtWExTT1l1dWJQOVZmT29vVVlGREREY0xYZw</guid><pubDate>Fri, 22 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFB2NE94ckxsd09xa0FUR3YtbktsMXVyd3lVSlVMd0tNdkx0S0FPOFU0am4tUjNyc09hTlZSeGdEVjNKeE8xQUQtdEJaWlJKUEJJSHEtWExTT1l1dWJQOVZmT29vVVlGREREY0xYZw?oc=5" target="_blank"&gt;아스텔라스는 '파·키·일·병' 구하기에 성공할 수 있을까&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>아스텔라스, 비어와 전립선암 치료제 신약 공동개발 - 의약뉴스</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE1TbjJBTk8ySHdVNEJjY2hWeVVZSHlHaDdSN2ZjZFdRU3VyZkhYY1lvRHYzaEVlX2ViX05iTDFScUZyV0RRYnlNSXAzM1NEV1ZvMG1hTzgwM2RWWDVBaDc4QWl3YzRDNEpO?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE1TbjJBTk8ySHdVNEJjY2hWeVVZSHlHaDdSN2ZjZFdRU3VyZkhYY1lvRHYzaEVlX2ViX05iTDFScUZyV0RRYnlNSXAzM1NEV1ZvMG1hTzgwM2RWWDVBaDc4QWl3YzRDNEpO</guid><pubDate>Tue, 24 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE1TbjJBTk8ySHdVNEJjY2hWeVVZSHlHaDdSN2ZjZFdRU3VyZkhYY1lvRHYzaEVlX2ViX05iTDFScUZyV0RRYnlNSXAzM1NEV1ZvMG1hTzgwM2RWWDVBaDc4QWl3YzRDNEpO?oc=5" target="_blank"&gt;아스텔라스, 비어와 전립선암 치료제 신약 공동개발&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의약뉴스&lt;/font&gt;</description><source url="https://www.newsmp.com">의약뉴스</source></item><item><title>아스텔라스 '세티데그라십' 췌관선암 3상 임상 착수 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE4xSExZNHdyeE5ZOWZXRHM3TmdKdEpRemxvdDM0XzNYQUV2TTdsMEI2RHY0RVQzZVFEM3lPNVQtVXFNb3RmcWlna2RBM3dmM3RtN29jMkdvVUdpRFkxZVJIZDRQN1QtRmdhb0E?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE4xSExZNHdyeE5ZOWZXRHM3TmdKdEpRemxvdDM0XzNYQUV2TTdsMEI2RHY0RVQzZVFEM3lPNVQtVXFNb3RmcWlna2RBM3dmM3RtN29jMkdvVUdpRFkxZVJIZDRQN1QtRmdhb0E</guid><pubDate>Fri, 17 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE4xSExZNHdyeE5ZOWZXRHM3TmdKdEpRemxvdDM0XzNYQUV2TTdsMEI2RHY0RVQzZVFEM3lPNVQtVXFNb3RmcWlna2RBM3dmM3RtN29jMkdvVUdpRFkxZVJIZDRQN1QtRmdhb0E?oc=5" target="_blank"&gt;아스텔라스 '세티데그라십' 췌관선암 3상 임상 착수&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>아스텔라스, KRAS G12D 표적 분해제 3상 진입…췌장암 치료 공략 - 메디코파마</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE1vanBHZF83bWhLYjdPXy1mcjF1ZHJfUjkwQkZCMmJ6OTlUS1lCTzl2UEtoRGhBU3M3ZUhVd1F3b21nU2VkWHAyUHZUSUtvT205Sm9YOGNEbTNjOHlHUVVZQW1iVmxaNngzZXE5SHd6cjRIZw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE1vanBHZF83bWhLYjdPXy1mcjF1ZHJfUjkwQkZCMmJ6OTlUS1lCTzl2UEtoRGhBU3M3ZUhVd1F3b21nU2VkWHAyUHZUSUtvT205Sm9YOGNEbTNjOHlHUVVZQW1iVmxaNngzZXE5SHd6cjRIZw</guid><pubDate>Mon, 20 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE1vanBHZF83bWhLYjdPXy1mcjF1ZHJfUjkwQkZCMmJ6OTlUS1lCTzl2UEtoRGhBU3M3ZUhVd1F3b21nU2VkWHAyUHZUSUtvT205Sm9YOGNEbTNjOHlHUVVZQW1iVmxaNngzZXE5SHd6cjRIZw?oc=5" target="_blank"&gt;아스텔라스, KRAS G12D 표적 분해제 3상 진입…췌장암 치료 공략&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디코파마&lt;/font&gt;</description><source url="https://www.medicopharma.co.kr">메디코파마</source></item><item><title>아스텔라스, 미르베트릭 특허 소송 합의… 실적 영향 검토 착수 - 금융경제플러스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5CcFdYX0tSQ0RvRlVfbEZtaGlpWmJ4OWpuM0YxT0doRGVZa3dRQWdQOHdpSVRzSTJFQV9PVGFiemRyZWlkaG4tLTBLSWFoYTVwTUd6cUtETzNqeFUzbUZRY21SeFpaa016aTFpOA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5CcFdYX0tSQ0RvRlVfbEZtaGlpWmJ4OWpuM0YxT0doRGVZa3dRQWdQOHdpSVRzSTJFQV9PVGFiemRyZWlkaG4tLTBLSWFoYTVwTUd6cUtETzNqeFUzbUZRY21SeFpaa016aTFpOA</guid><pubDate>Tue, 10 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5CcFdYX0tSQ0RvRlVfbEZtaGlpWmJ4OWpuM0YxT0doRGVZa3dRQWdQOHdpSVRzSTJFQV9PVGFiemRyZWlkaG4tLTBLSWFoYTVwTUd6cUtETzNqeFUzbUZRY21SeFpaa016aTFpOA?oc=5" target="_blank"&gt;아스텔라스, 미르베트릭 특허 소송 합의… 실적 영향 검토 착수&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;금융경제플러스&lt;/font&gt;</description><source url="https://www.kndaily.co.kr">금융경제플러스</source></item><item><title>이선희 전무, 아스텔라스 이집트 법인 대표 취임...글로벌 인재 육성 전략 일환 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9YZW1oZVREWVRqMU1nRDVxdXM2aWdIWkFhVThDYVlja0xtQnFpSnplZkpSSkpVcWlRekNYdXRzZ1VUcE4tNDZuUmlESVNiV2xEQ2ZyVHE4Tm5tT3N4WHJWTDEzX3BjczMwZDVybw?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9YZW1oZVREWVRqMU1nRDVxdXM2aWdIWkFhVThDYVlja0xtQnFpSnplZkpSSkpVcWlRekNYdXRzZ1VUcE4tNDZuUmlESVNiV2xEQ2ZyVHE4Tm5tT3N4WHJWTDEzX3BjczMwZDVybw</guid><pubDate>Mon, 21 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9YZW1oZVREWVRqMU1nRDVxdXM2aWdIWkFhVThDYVlja0xtQnFpSnplZkpSSkpVcWlRekNYdXRzZ1VUcE4tNDZuUmlESVNiV2xEQ2ZyVHE4Tm5tT3N4WHJWTDEzX3BjczMwZDVybw?oc=5" target="_blank"&gt;이선희 전무, 아스텔라스 이집트 법인 대표 취임...글로벌 인재 육성 전략 일환&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>특허만료 앞둔 엑스탄디, 내달 정제 등재로 시장 방어 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTE8za0hzamNPVFhVNkhTN1kzMVhXakMwNVE0LWdaTjZ4YUlrd3dqRnJhMEpIazgwbWpMQWFpbTduSEgtZEo0QUF3dVQtZzFoczVyeFZWSEp3?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTE8za0hzamNPVFhVNkhTN1kzMVhXakMwNVE0LWdaTjZ4YUlrd3dqRnJhMEpIazgwbWpMQWFpbTduSEgtZEo0QUF3dVQtZzFoczVyeFZWSEp3</guid><pubDate>Thu, 19 Mar 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE8za0hzamNPVFhVNkhTN1kzMVhXakMwNVE0LWdaTjZ4YUlrd3dqRnJhMEpIazgwbWpMQWFpbTduSEgtZEo0QUF3dVQtZzFoczVyeFZWSEp3?oc=5" target="_blank"&gt;특허만료 앞둔 엑스탄디, 내달 정제 등재로 시장 방어&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://www.dailypharm.com">데일리팜</source></item><item><title>1차 이어 2차 치료까지…빌로이, 위암서 CLDN18.2 표적치료 확장 시험대 - 메디코파마</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTFB5RDNMLUg1V0pWNHQwdUZiNmlrNWNkN0pYX2JHVUpnUzkxZkNFUW05UnlMQ2hqZEhfZlZ1Vzc4RG1WWEpxYVA5SGo1YTRWaUFITHk4c3h4WEgzX0NlUjFINDNtWVpUbEhWZnRBSEdDR1I2dw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTFB5RDNMLUg1V0pWNHQwdUZiNmlrNWNkN0pYX2JHVUpnUzkxZkNFUW05UnlMQ2hqZEhfZlZ1Vzc4RG1WWEpxYVA5SGo1YTRWaUFITHk4c3h4WEgzX0NlUjFINDNtWVpUbEhWZnRBSEdDR1I2dw</guid><pubDate>Tue, 13 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTFB5RDNMLUg1V0pWNHQwdUZiNmlrNWNkN0pYX2JHVUpnUzkxZkNFUW05UnlMQ2hqZEhfZlZ1Vzc4RG1WWEpxYVA5SGo1YTRWaUFITHk4c3h4WEgzX0NlUjFINDNtWVpUbEhWZnRBSEdDR1I2dw?oc=5" target="_blank"&gt;1차 이어 2차 치료까지…빌로이, 위암서 CLDN18.2 표적치료 확장 시험대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디코파마&lt;/font&gt;</description><source url="https://www.medicopharma.co.kr">메디코파마</source></item><item><title>아스텔라스 제약, 2025 회계연도 매출 2.1조 엔 돌파…핵심 이익 42% 급증 - Investing.com 한국어</title><link>https://news.google.com/rss/articles/CBMicEFVX3lxTE1OUFRWS3ZBaHNrS2J1RUdtM3BFRC1kSFN5RzF3SUVNR25uX2xfcUdxR016d1pabVh6MWJwMUw3UGcwTk42NW9wRF9WNFlkdjVsQ3RadUhqUE9aX3llNm5tU2tLU3FESzhPcy1FR01GWUo?oc=5</link><guid isPermaLink="false">CBMicEFVX3lxTE1OUFRWS3ZBaHNrS2J1RUdtM3BFRC1kSFN5RzF3SUVNR25uX2xfcUdxR016d1pabVh6MWJwMUw3UGcwTk42NW9wRF9WNFlkdjVsQ3RadUhqUE9aX3llNm5tU2tLU3FESzhPcy1FR01GWUo</guid><pubDate>Tue, 28 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE1OUFRWS3ZBaHNrS2J1RUdtM3BFRC1kSFN5RzF3SUVNR25uX2xfcUdxR016d1pabVh6MWJwMUw3UGcwTk42NW9wRF9WNFlkdjVsQ3RadUhqUE9aX3llNm5tU2tLU3FESzhPcy1FR01GWUo?oc=5" target="_blank"&gt;아스텔라스 제약, 2025 회계연도 매출 2.1조 엔 돌파…핵심 이익 42% 급증&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Investing.com 한국어&lt;/font&gt;</description><source url="https://kr.investing.com">Investing.com 한국어</source></item><item><title>日 아스텔라스, ‘바이로이’ 병용요법 CLDN18.2 고발현 위암 PFS 격차 뚜렷 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE1IVl9VMklyOVNGbVZQZUZkSm84QWxjZnJKblVZVm44ZU5udHVUR1l3S2NUTkZ4RGlZcW9UdXBXMlVSeF9MSVlqeTgzSHlVY1M2WEtwVHNWZGtHeURHNy1SVVl5dWtPSWk1OW5VS9IBcEFVX3lxTE44cEpKZWNsSHhFTVlwVndfN0NRUUR3emI0X1l3R3ZhdzlYNDRBZlQteEk4MVNZcUwtSmVubEh5VHB4UGZrNWtvQ25hZWxEY283T05ycDQtell6YkxZNnplZVZNcERoYXpqeU0zeE54bm8?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE1IVl9VMklyOVNGbVZQZUZkSm84QWxjZnJKblVZVm44ZU5udHVUR1l3S2NUTkZ4RGlZcW9UdXBXMlVSeF9MSVlqeTgzSHlVY1M2WEtwVHNWZGtHeURHNy1SVVl5dWtPSWk1OW5VS9IBcEFVX3lxTE44cEpKZWNsSHhFTVlwVndfN0NRUUR3emI0X1l3R3ZhdzlYNDRBZlQteEk4MVNZcUwtSmVubEh5VHB4UGZrNWtvQ25hZWxEY283T05ycDQtell6YkxZNnplZVZNcERoYXpqeU0zeE54bm8</guid><pubDate>Thu, 15 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1IVl9VMklyOVNGbVZQZUZkSm84QWxjZnJKblVZVm44ZU5udHVUR1l3S2NUTkZ4RGlZcW9UdXBXMlVSeF9MSVlqeTgzSHlVY1M2WEtwVHNWZGtHeURHNy1SVVl5dWtPSWk1OW5VS9IBcEFVX3lxTE44cEpKZWNsSHhFTVlwVndfN0NRUUR3emI0X1l3R3ZhdzlYNDRBZlQteEk4MVNZcUwtSmVubEh5VHB4UGZrNWtvQ25hZWxEY283T05ycDQtell6YkxZNnplZVZNcERoYXpqeU0zeE54bm8?oc=5" target="_blank"&gt;日 아스텔라스, ‘바이로이’ 병용요법 CLDN18.2 고발현 위암 PFS 격차 뚜렷&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>美 FDA 승인 이어 일본 접수 나선 ‘페졸리네탄트’… 아스텔라스 블록버스터 기대감↑ - 금융경제플러스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9yRGo3S0h6TEdjOUo0djU0V3laLUZNSUg5LXBucnBIUHg5eGxvOVJFYnUycmxlWFhwRl85OUFYNVFQbHFneUkwclRXM2xjVS1nSnR1TXNaRFRhY0pFS1M4Z09vaE5wUkxyT0lfWQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9yRGo3S0h6TEdjOUo0djU0V3laLUZNSUg5LXBucnBIUHg5eGxvOVJFYnUycmxlWFhwRl85OUFYNVFQbHFneUkwclRXM2xjVS1nSnR1TXNaRFRhY0pFS1M4Z09vaE5wUkxyT0lfWQ</guid><pubDate>Tue, 03 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9yRGo3S0h6TEdjOUo0djU0V3laLUZNSUg5LXBucnBIUHg5eGxvOVJFYnUycmxlWFhwRl85OUFYNVFQbHFneUkwclRXM2xjVS1nSnR1TXNaRFRhY0pFS1M4Z09vaE5wUkxyT0lfWQ?oc=5" target="_blank"&gt;美 FDA 승인 이어 일본 접수 나선 ‘페졸리네탄트’… 아스텔라스 블록버스터 기대감↑&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;금융경제플러스&lt;/font&gt;</description><source url="https://www.kndaily.co.kr">금융경제플러스</source></item><item><title>아스텔라스 ‘베솜니서방정’, 전립선비대증 시장 ‘태풍의 눈’ 오나 - 메디소비자뉴스</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTFBHSnRtcnZBMC1yNTRScEQwbTNsNlg4ZmtSTXFoUzdBTXBYRVloX01PcHNYcENBRl9iRTRwMHZSQWxzdTBTUFpDbXQ4WjBDSzFLNkE4aWczNllHS2tLdmhBemtwb2ZSOGl6MHRKYWRNbGZQQdIBdkFVX3lxTFB5YzJRTWhhYTZOSExSWElpTXIwN0lpZW1na00xVHhqR1RoeGpMOEF3UTl1OFk1Q0RWZklvVnVXa3hNeUJHWHByV0RicE1GYlI1V19zWlkxUUZDREpiQzhKa3hOdHRCekMxX0JPSlhMeTJTMjdnRmc?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTFBHSnRtcnZBMC1yNTRScEQwbTNsNlg4ZmtSTXFoUzdBTXBYRVloX01PcHNYcENBRl9iRTRwMHZSQWxzdTBTUFpDbXQ4WjBDSzFLNkE4aWczNllHS2tLdmhBemtwb2ZSOGl6MHRKYWRNbGZQQdIBdkFVX3lxTFB5YzJRTWhhYTZOSExSWElpTXIwN0lpZW1na00xVHhqR1RoeGpMOEF3UTl1OFk1Q0RWZklvVnVXa3hNeUJHWHByV0RicE1GYlI1V19zWlkxUUZDREpiQzhKa3hOdHRCekMxX0JPSlhMeTJTMjdnRmc</guid><pubDate>Tue, 09 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTFBHSnRtcnZBMC1yNTRScEQwbTNsNlg4ZmtSTXFoUzdBTXBYRVloX01PcHNYcENBRl9iRTRwMHZSQWxzdTBTUFpDbXQ4WjBDSzFLNkE4aWczNllHS2tLdmhBemtwb2ZSOGl6MHRKYWRNbGZQQdIBdkFVX3lxTFB5YzJRTWhhYTZOSExSWElpTXIwN0lpZW1na00xVHhqR1RoeGpMOEF3UTl1OFk1Q0RWZklvVnVXa3hNeUJHWHByV0RicE1GYlI1V19zWlkxUUZDREpiQzhKa3hOdHRCekMxX0JPSlhMeTJTMjdnRmc?oc=5" target="_blank"&gt;아스텔라스 ‘베솜니서방정’, 전립선비대증 시장 ‘태풍의 눈’ 오나&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디소비자뉴스&lt;/font&gt;</description><source url="http://www.medisobizanews.com">메디소비자뉴스</source></item><item><title>연탄 13만장·기부 10억원 … 한국아스텔라스 '희망기금' 15년 - 매일경제</title><link>https://news.google.com/rss/articles/CBMiTkFVX3lxTE1iVkRuV3ZfVkdDVEVwcEZXU1RmRkoyOE5ZaU81UVlqQzZQMDhtVWJzZVNpLUh3ck5ZQW5UNlM3ZEN6a2lOYi1QQ1hVb202QQ?oc=5</link><guid isPermaLink="false">CBMiTkFVX3lxTE1iVkRuV3ZfVkdDVEVwcEZXU1RmRkoyOE5ZaU81UVlqQzZQMDhtVWJzZVNpLUh3ck5ZQW5UNlM3ZEN6a2lOYi1QQ1hVb202QQ</guid><pubDate>Mon, 05 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiTkFVX3lxTE1iVkRuV3ZfVkdDVEVwcEZXU1RmRkoyOE5ZaU81UVlqQzZQMDhtVWJzZVNpLUh3ck5ZQW5UNlM3ZEN6a2lOYi1QQ1hVb202QQ?oc=5" target="_blank"&gt;연탄 13만장·기부 10억원 … 한국아스텔라스 '희망기금' 15년&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;매일경제&lt;/font&gt;</description><source url="https://www.mk.co.kr">매일경제</source></item><item><title>한국아스텔라스, 복용 편의성 개선 ‘베솜니서방정’ 출시...런칭 심포지엄 개최 - 데일리메디팜</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE5EZVdkbFo0S0x1Z19WWWxBaUtLeFFEenZfT0pMZkYyeF9TZ21PREMzeWVROF9tNDVHMTlQSXYwcHhuQWk2WHplMVAxbEpqSjRSeE8yVC1KUFhDSk1zTGpzSVc2THhNOVVya1h0Zkln?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE5EZVdkbFo0S0x1Z19WWWxBaUtLeFFEenZfT0pMZkYyeF9TZ21PREMzeWVROF9tNDVHMTlQSXYwcHhuQWk2WHplMVAxbEpqSjRSeE8yVC1KUFhDSk1zTGpzSVc2THhNOVVya1h0Zkln</guid><pubDate>Sat, 02 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5EZVdkbFo0S0x1Z19WWWxBaUtLeFFEenZfT0pMZkYyeF9TZ21PREMzeWVROF9tNDVHMTlQSXYwcHhuQWk2WHplMVAxbEpqSjRSeE8yVC1KUFhDSk1zTGpzSVc2THhNOVVya1h0Zkln?oc=5" target="_blank"&gt;한국아스텔라스, 복용 편의성 개선 ‘베솜니서방정’ 출시...런칭 심포지엄 개최&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리메디팜&lt;/font&gt;</description><source url="http://m.dailymedipharm.com">데일리메디팜</source></item><item><title>한국아스텔라스, 신임 마켓액세스 총괄에 백소영 상무 선임 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9pOFJneUJoOXhjRnZSSWNjUTNLN21pQnF5N2pjRFdlT0M1LUtZbVVaajVzOFRVZm5pcDh2SnlzN0VzVldIYWdrSUcyeExYVjRWMnVhSGVZNm50ZWN6dVdnLXVQaU9IbFJFMnZPVg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9pOFJneUJoOXhjRnZSSWNjUTNLN21pQnF5N2pjRFdlT0M1LUtZbVVaajVzOFRVZm5pcDh2SnlzN0VzVldIYWdrSUcyeExYVjRWMnVhSGVZNm50ZWN6dVdnLXVQaU9IbFJFMnZPVg</guid><pubDate>Tue, 01 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9pOFJneUJoOXhjRnZSSWNjUTNLN21pQnF5N2pjRFdlT0M1LUtZbVVaajVzOFRVZm5pcDh2SnlzN0VzVldIYWdrSUcyeExYVjRWMnVhSGVZNm50ZWN6dVdnLXVQaU9IbFJFMnZPVg?oc=5" target="_blank"&gt;한국아스텔라스, 신임 마켓액세스 총괄에 백소영 상무 선임&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>한국아스텔라스, 티큐브잇·아바타테라퓨틱스 2곳에 日 츠쿠바연구소 입주 혜택 제공 … 日 제약사 최초 창업진흥원과 업무협약 - 헬스오</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE80am9tS2VVSUx3RzZ4U0p6a2t3MmdhbUlsX1hBaWgzY1NZWXU0OXZiR1pCZ1NvdEwtR0U0d052Z3R4MU9XR2NMQTAycWlnQ2Y5TkRiTg?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE80am9tS2VVSUx3RzZ4U0p6a2t3MmdhbUlsX1hBaWgzY1NZWXU0OXZiR1pCZ1NvdEwtR0U0d052Z3R4MU9XR2NMQTAycWlnQ2Y5TkRiTg</guid><pubDate>Thu, 24 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE80am9tS2VVSUx3RzZ4U0p6a2t3MmdhbUlsX1hBaWgzY1NZWXU0OXZiR1pCZ1NvdEwtR0U0d052Z3R4MU9XR2NMQTAycWlnQ2Y5TkRiTg?oc=5" target="_blank"&gt;한국아스텔라스, 티큐브잇·아바타테라퓨틱스 2곳에 日 츠쿠바연구소 입주 혜택 제공 … 日 제약사 최초 창업진흥원과 업무협약&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스오&lt;/font&gt;</description><source url="http://healtho.co.kr">헬스오</source></item><item><title>아스텔라스, 장기기증 인식 제고 '구하자9' 캠페인 성료 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5IVWJpeWdHMWUxa1p4cmN2amxoenloVmNYWWZMd1JscUhiXzRYN3NnUTdaYTM5eVZ1b1VXR1RJNWdENTdDSi1JZ1NmVmZ1bWZVUWlfOERicmJuU1UtS0VWcVhCYjBGY2JnTVBqVA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5IVWJpeWdHMWUxa1p4cmN2amxoenloVmNYWWZMd1JscUhiXzRYN3NnUTdaYTM5eVZ1b1VXR1RJNWdENTdDSi1JZ1NmVmZ1bWZVUWlfOERicmJuU1UtS0VWcVhCYjBGY2JnTVBqVA</guid><pubDate>Wed, 10 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5IVWJpeWdHMWUxa1p4cmN2amxoenloVmNYWWZMd1JscUhiXzRYN3NnUTdaYTM5eVZ1b1VXR1RJNWdENTdDSi1JZ1NmVmZ1bWZVUWlfOERicmJuU1UtS0VWcVhCYjBGY2JnTVBqVA?oc=5" target="_blank"&gt;아스텔라스, 장기기증 인식 제고 '구하자9' 캠페인 성료&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>엔허투 급여 전문가 한국아스텔라스로, 신임 MA 총괄에 백소영 상무 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBrQy1sTkVZOEc1dEh6alM3QkoxX1kzeXFLTlJMRVdlbzZBaEZoa1JYTjd1QkYwTzlOdjVxY1owWWJwSmVoZGtuSE4tZUtLbTBTdnVIakRVYkdpMEo5WGxzOFQ5SlBtSTBCU2tlSA?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBrQy1sTkVZOEc1dEh6alM3QkoxX1kzeXFLTlJMRVdlbzZBaEZoa1JYTjd1QkYwTzlOdjVxY1owWWJwSmVoZGtuSE4tZUtLbTBTdnVIakRVYkdpMEo5WGxzOFQ5SlBtSTBCU2tlSA</guid><pubDate>Tue, 01 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBrQy1sTkVZOEc1dEh6alM3QkoxX1kzeXFLTlJMRVdlbzZBaEZoa1JYTjd1QkYwTzlOdjVxY1owWWJwSmVoZGtuSE4tZUtLbTBTdnVIakRVYkdpMEo5WGxzOFQ5SlBtSTBCU2tlSA?oc=5" target="_blank"&gt;엔허투 급여 전문가 한국아스텔라스로, 신임 MA 총괄에 백소영 상무&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>아스텔라스, ﻿파드셉 병용요법 급여 위한 적극 행보 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBVc0VWR21BRGxta1pWZFhUVGg4VWpCX2l5UGxHWTl5OHpDd1pDOGRjT1pINUVQbVo1ODJCYzFmNW81LWFMb3dPM0J2UHhlSmRjZWNxRVVGelM2WTNGT0kyZ1NJWllMaW8xZlNV?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBVc0VWR21BRGxta1pWZFhUVGg4VWpCX2l5UGxHWTl5OHpDd1pDOGRjT1pINUVQbVo1ODJCYzFmNW81LWFMb3dPM0J2UHhlSmRjZWNxRVVGelM2WTNGT0kyZ1NJWllMaW8xZlNV</guid><pubDate>Thu, 14 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBVc0VWR21BRGxta1pWZFhUVGg4VWpCX2l5UGxHWTl5OHpDd1pDOGRjT1pINUVQbVo1ODJCYzFmNW81LWFMb3dPM0J2UHhlSmRjZWNxRVVGelM2WTNGT0kyZ1NJWllMaW8xZlNV?oc=5" target="_blank"&gt;아스텔라스, ﻿파드셉 병용요법 급여 위한 적극 행보&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>비호르몬 폐경기 시장 불붙었다…바이엘 vs 아스텔라스 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBhWVQ3R2NmV0kwVWN2SmVzZzBCSjhLczEyV2NyOGZUTnNiQS1RcV90V2k5dkRKTVFEZ0tOXzNudlVQOHZwTmg0T0pVVE1NMEFZdnNlMmFpaVdzcWw5MUY5N3R4dGVfbXgtSXl2Ng?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBhWVQ3R2NmV0kwVWN2SmVzZzBCSjhLczEyV2NyOGZUTnNiQS1RcV90V2k5dkRKTVFEZ0tOXzNudlVQOHZwTmg0T0pVVE1NMEFZdnNlMmFpaVdzcWw5MUY5N3R4dGVfbXgtSXl2Ng</guid><pubDate>Mon, 27 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBhWVQ3R2NmV0kwVWN2SmVzZzBCSjhLczEyV2NyOGZUTnNiQS1RcV90V2k5dkRKTVFEZ0tOXzNudlVQOHZwTmg0T0pVVE1NMEFZdnNlMmFpaVdzcWw5MUY5N3R4dGVfbXgtSXl2Ng?oc=5" target="_blank"&gt;비호르몬 폐경기 시장 불붙었다…바이엘 vs 아스텔라스&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>파드셉 병용요법, 선제적 재정분담안으로 9월 암질심 재도전 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5vTVhqOWpTVDZuSDhweXBNMHpQZWZTVXV2NU12ZFpmS0tHRW1VbGVmVkxtRk9CVnFHTWt1N2VDMjlwQlhiYmQ0RGhMd1NwY0tfMGxCN3YxUzJGR3dkUzRqN2pudkk0aW42Y0E?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5vTVhqOWpTVDZuSDhweXBNMHpQZWZTVXV2NU12ZFpmS0tHRW1VbGVmVkxtRk9CVnFHTWt1N2VDMjlwQlhiYmQ0RGhMd1NwY0tfMGxCN3YxUzJGR3dkUzRqN2pudkk0aW42Y0E</guid><pubDate>Tue, 19 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5vTVhqOWpTVDZuSDhweXBNMHpQZWZTVXV2NU12ZFpmS0tHRW1VbGVmVkxtRk9CVnFHTWt1N2VDMjlwQlhiYmQ0RGhMd1NwY0tfMGxCN3YxUzJGR3dkUzRqN2pudkk0aW42Y0E?oc=5" target="_blank"&gt;파드셉 병용요법, 선제적 재정분담안으로 9월 암질심 재도전&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="http://www.hitnews.co.kr">히트뉴스</source></item><item><title>아스텔라스, '파드셉' 英전이성 요로상피암 1차 병용요법 급여 승인 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE4tRHBmMTFJRm95MDVXWE5pNGZZcldSTm9ETGxYa0RKQ1FxMnlJSHk5RVVsOEd1c1dYcmtRT0FBYWxlOXF1VnNKMFExUXJrZ3NCdXVvXzdSdmJPWXZPX2pXMlBVazZiaTZDQ2Y4cg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE4tRHBmMTFJRm95MDVXWE5pNGZZcldSTm9ETGxYa0RKQ1FxMnlJSHk5RVVsOEd1c1dYcmtRT0FBYWxlOXF1VnNKMFExUXJrZ3NCdXVvXzdSdmJPWXZPX2pXMlBVazZiaTZDQ2Y4cg</guid><pubDate>Thu, 04 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE4tRHBmMTFJRm95MDVXWE5pNGZZcldSTm9ETGxYa0RKQ1FxMnlJSHk5RVVsOEd1c1dYcmtRT0FBYWxlOXF1VnNKMFExUXJrZ3NCdXVvXzdSdmJPWXZPX2pXMlBVazZiaTZDQ2Y4cg?oc=5" target="_blank"&gt;아스텔라스, '파드셉' 英전이성 요로상피암 1차 병용요법 급여 승인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>한국아스텔라스 파드셉 암질심 실패 후 3개월만 급여 재도전 성공할까? - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5wTTQ4NmMzbWNBbWxIZEJyNHQtcGNqS2oyWUpCYnFsa2NhSE40NjlUUFJWQzUzcVpPTUFoQ0RwN2h1TGpKcFFONHFwSElReXJSWmFmUWF1VEgwU082NktPMDZHRWZLWVhIUmc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5wTTQ4NmMzbWNBbWxIZEJyNHQtcGNqS2oyWUpCYnFsa2NhSE40NjlUUFJWQzUzcVpPTUFoQ0RwN2h1TGpKcFFONHFwSElReXJSWmFmUWF1VEgwU082NktPMDZHRWZLWVhIUmc</guid><pubDate>Mon, 18 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5wTTQ4NmMzbWNBbWxIZEJyNHQtcGNqS2oyWUpCYnFsa2NhSE40NjlUUFJWQzUzcVpPTUFoQ0RwN2h1TGpKcFFONHFwSElReXJSWmFmUWF1VEgwU082NktPMDZHRWZLWVhIUmc?oc=5" target="_blank"&gt;한국아스텔라스 파드셉 암질심 실패 후 3개월만 급여 재도전 성공할까?&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>[ESMO] 화이자·아스텔라스, ‘엑스탄디’ 비전이성 전립선암 사망 위험 40%↓ - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9nek1qOERsV2lNQjlOb2p5cnc3emZpZFZGMThnWFVOTDhWY0JVN0Rpc2l0eWF6NFJoMmlmME0yMHBfc3NiM0ZEQ0J5QW5fSWtiZVRUcTJOQU0zNlV5SzB4VlZvYUJMYzloalFnRdIBcEFVX3lxTE55dVBiS0FiTTRtc0lDZFVRQzNUd1h3bW5OWm5yX3lfNXpkckhocklvWGRvWUpjdkdmQ1QxWktCdkZlRC1SX3NvMzJGS1JTSm1wTzA1VGtQQVpRQ2FfRGpGdm9RTWowYWluOHZKSlpYMXk?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9nek1qOERsV2lNQjlOb2p5cnc3emZpZFZGMThnWFVOTDhWY0JVN0Rpc2l0eWF6NFJoMmlmME0yMHBfc3NiM0ZEQ0J5QW5fSWtiZVRUcTJOQU0zNlV5SzB4VlZvYUJMYzloalFnRdIBcEFVX3lxTE55dVBiS0FiTTRtc0lDZFVRQzNUd1h3bW5OWm5yX3lfNXpkckhocklvWGRvWUpjdkdmQ1QxWktCdkZlRC1SX3NvMzJGS1JTSm1wTzA1VGtQQVpRQ2FfRGpGdm9RTWowYWluOHZKSlpYMXk</guid><pubDate>Tue, 21 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9nek1qOERsV2lNQjlOb2p5cnc3emZpZFZGMThnWFVOTDhWY0JVN0Rpc2l0eWF6NFJoMmlmME0yMHBfc3NiM0ZEQ0J5QW5fSWtiZVRUcTJOQU0zNlV5SzB4VlZvYUJMYzloalFnRdIBcEFVX3lxTE55dVBiS0FiTTRtc0lDZFVRQzNUd1h3bW5OWm5yX3lfNXpkckhocklvWGRvWUpjdkdmQ1QxWktCdkZlRC1SX3NvMzJGS1JTSm1wTzA1VGtQQVpRQ2FfRGpGdm9RTWowYWluOHZKSlpYMXk?oc=5" target="_blank"&gt;[ESMO] 화이자·아스텔라스, ‘엑스탄디’ 비전이성 전립선암 사망 위험 40%↓&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>전립선암 표준치료제 아스텔라스社 ‘엔잘루타미드’ 약물저항성 예측 ‘지도’ 나왔다 - 헬스오</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE8wTC1tbXJCUkNxRG1zLVVRaHpubXBBVkc4eHBTWlRJVE5RczRTYURMNElTd2k5Y0tld1JrVlZodWdJRnlObUlvUHpOQ2lSMC1nektvckphU0FlUQ?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE8wTC1tbXJCUkNxRG1zLVVRaHpubXBBVkc4eHBTWlRJVE5RczRTYURMNElTd2k5Y0tld1JrVlZodWdJRnlObUlvUHpOQ2lSMC1nektvckphU0FlUQ</guid><pubDate>Thu, 09 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE8wTC1tbXJCUkNxRG1zLVVRaHpubXBBVkc4eHBTWlRJVE5RczRTYURMNElTd2k5Y0tld1JrVlZodWdJRnlObUlvUHpOQ2lSMC1nektvckphU0FlUQ?oc=5" target="_blank"&gt;전립선암 표준치료제 아스텔라스社 ‘엔잘루타미드’ 약물저항성 예측 ‘지도’ 나왔다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;헬스오&lt;/font&gt;</description><source url="https://healtho.co.kr">헬스오</source></item><item><title>한국아스텔라스, 신임 마켓액세스 총괄 백소영 상무 선임 - 약업신문</title><link>https://news.google.com/rss/articles/CBMid0FVX3lxTFB2N3NxVFBPMmhZc3ZSZTd4UVlTTFg5MVM1aVhvRU1qOXZkekRYQnhQdm94XzZQdks4alVMeWU1cGc2OTdyRkhucjQxbEU2NkVnbEVVaC1NOXdVWERuQ3YwSGhpMkNHcnN3Q3BTNUowLW45X3hwVEpv?oc=5</link><guid isPermaLink="false">CBMid0FVX3lxTFB2N3NxVFBPMmhZc3ZSZTd4UVlTTFg5MVM1aVhvRU1qOXZkekRYQnhQdm94XzZQdks4alVMeWU1cGc2OTdyRkhucjQxbEU2NkVnbEVVaC1NOXdVWERuQ3YwSGhpMkNHcnN3Q3BTNUowLW45X3hwVEpv</guid><pubDate>Tue, 01 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFB2N3NxVFBPMmhZc3ZSZTd4UVlTTFg5MVM1aVhvRU1qOXZkekRYQnhQdm94XzZQdks4alVMeWU1cGc2OTdyRkhucjQxbEU2NkVnbEVVaC1NOXdVWERuQ3YwSGhpMkNHcnN3Q3BTNUowLW45X3hwVEpv?oc=5" target="_blank"&gt;한국아스텔라스, 신임 마켓액세스 총괄 백소영 상무 선임&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>'빌로이' 췌장암 임상서 1차 평가항목 달성 실패 - 의학신문</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBGMG1jbGRJQ3JGMG9MMnQ3akk0d181bFdvRlZVRmxWZGdLSEFGc0g2bl85cjJLVURXY0stV2xvWVQ1WUFDMDBDdjVMWXIzZzdrdG00Sm8wcFhYRW9pbnBFWlN2TmpiS05VMlE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBGMG1jbGRJQ3JGMG9MMnQ3akk0d181bFdvRlZVRmxWZGdLSEFGc0g2bl85cjJLVURXY0stV2xvWVQ1WUFDMDBDdjVMWXIzZzdrdG00Sm8wcFhYRW9pbnBFWlN2TmpiS05VMlE</guid><pubDate>Thu, 16 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBGMG1jbGRJQ3JGMG9MMnQ3akk0d181bFdvRlZVRmxWZGdLSEFGc0g2bl85cjJLVURXY0stV2xvWVQ1WUFDMDBDdjVMWXIzZzdrdG00Sm8wcFhYRW9pbnBFWlN2TmpiS05VMlE?oc=5" target="_blank"&gt;'빌로이' 췌장암 임상서 1차 평가항목 달성 실패&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의학신문&lt;/font&gt;</description><source url="https://www.bosa.co.kr">의학신문</source></item><item><title>창업진흥원, 아스텔라스 제약과 협력체계 구축 - 매일일보</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTE9BSk11NjR6eWljenZEcS1OVkIwekMwNUtnUG5ZQ09mMklzamRqdkNPcVBwdTJLZTA1UlY2OVJJZDZaYzZGeGE0dG45akNxcWctOTdBN2lWVUhMaVlsbzNGS01JWmE?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTE9BSk11NjR6eWljenZEcS1OVkIwekMwNUtnUG5ZQ09mMklzamRqdkNPcVBwdTJLZTA1UlY2OVJJZDZaYzZGeGE0dG45akNxcWctOTdBN2lWVUhMaVlsbzNGS01JWmE</guid><pubDate>Tue, 15 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE9BSk11NjR6eWljenZEcS1OVkIwekMwNUtnUG5ZQ09mMklzamRqdkNPcVBwdTJLZTA1UlY2OVJJZDZaYzZGeGE0dG45akNxcWctOTdBN2lWVUhMaVlsbzNGS01JWmE?oc=5" target="_blank"&gt;창업진흥원, 아스텔라스 제약과 협력체계 구축&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;매일일보&lt;/font&gt;</description><source url="https://www.m-i.kr">매일일보</source></item><item><title>아스텔라스, 비르와 협력하여 실험용 전립선암 치료제 개발 - TradingView</title><link>https://news.google.com/rss/articles/CBMid0FVX3lxTE5YMjduMlBVQnpyZGR2X2NqRldVRExoVGoyVEM4N0tEWG1WbDJXMFNzZThWZTNHZFZIdFliOTU0Q1FNMnJ2M1R5ZUFCR2NYclJLVUp1LUJhN0NqaHhDYnFZaGxaN0psSE8xeEhReU1fVnAyaE1iYm5F?oc=5</link><guid isPermaLink="false">CBMid0FVX3lxTE5YMjduMlBVQnpyZGR2X2NqRldVRExoVGoyVEM4N0tEWG1WbDJXMFNzZThWZTNHZFZIdFliOTU0Q1FNMnJ2M1R5ZUFCR2NYclJLVUp1LUJhN0NqaHhDYnFZaGxaN0psSE8xeEhReU1fVnAyaE1iYm5F</guid><pubDate>Mon, 23 Feb 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE5YMjduMlBVQnpyZGR2X2NqRldVRExoVGoyVEM4N0tEWG1WbDJXMFNzZThWZTNHZFZIdFliOTU0Q1FNMnJ2M1R5ZUFCR2NYclJLVUp1LUJhN0NqaHhDYnFZaGxaN0psSE8xeEhReU1fVnAyaE1iYm5F?oc=5" target="_blank"&gt;아스텔라스, 비르와 협력하여 실험용 전립선암 치료제 개발&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;TradingView&lt;/font&gt;</description><source url="https://id.tradingview.com">TradingView</source></item><item><title>한국아스텔라스 이선희 전무, 아스텔라스 이집트 사장 임명 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiX0FVX3lxTE11OXVNMDE1aXdXOExMSFVIS0xyLTdzYVY5WS1TYWwybHVwTHktUkY2X0ZzODJhcWRZaWVHeExDM2FCZGl3UVBGT2o1RDc3Q1NDb1ROSGJiX01GUHh2eVVJ?oc=5</link><guid isPermaLink="false">CBMiX0FVX3lxTE11OXVNMDE1aXdXOExMSFVIS0xyLTdzYVY5WS1TYWwybHVwTHktUkY2X0ZzODJhcWRZaWVHeExDM2FCZGl3UVBGT2o1RDc3Q1NDb1ROSGJiX01GUHh2eVVJ</guid><pubDate>Mon, 21 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE11OXVNMDE1aXdXOExMSFVIS0xyLTdzYVY5WS1TYWwybHVwTHktUkY2X0ZzODJhcWRZaWVHeExDM2FCZGl3UVBGT2o1RDc3Q1NDb1ROSGJiX01GUHh2eVVJ?oc=5" target="_blank"&gt;한국아스텔라스 이선희 전무, 아스텔라스 이집트 사장 임명&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>아스텔라스, '아이저베이' 1분기 부진 딛고 2분기 '반등' - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5HaVBzMl81eXRTbU5CWnBzdkdCQ19FdFpBckUzN2tTc2lDWTJhdWxtcUR2Z2g4Z3lxRjdlU2EybzhLYlh6NG03eWxZSzBLTHJDRXdKQUhRVHJJRjNvai04N0RnZ0M4N25TM2RmbQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5HaVBzMl81eXRTbU5CWnBzdkdCQ19FdFpBckUzN2tTc2lDWTJhdWxtcUR2Z2g4Z3lxRjdlU2EybzhLYlh6NG03eWxZSzBLTHJDRXdKQUhRVHJJRjNvai04N0RnZ0M4N25TM2RmbQ</guid><pubDate>Mon, 14 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5HaVBzMl81eXRTbU5CWnBzdkdCQ19FdFpBckUzN2tTc2lDWTJhdWxtcUR2Z2g4Z3lxRjdlU2EybzhLYlh6NG03eWxZSzBLTHJDRXdKQUhRVHJJRjNvai04N0RnZ0M4N25TM2RmbQ?oc=5" target="_blank"&gt;아스텔라스, '아이저베이' 1분기 부진 딛고 2분기 '반등'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>아스텔라스 이집트 사장에 이선희 한국아스텔라스 전무 임명 - 지디넷코리아</title><link>https://news.google.com/rss/articles/CBMiVkFVX3lxTFB3LWRXZ2JuOW5DX1N5T0xUNnNKY3gzdDRIenFwRWV1cUUyQk5xclpKWnJZQVNHX1g0c2RKTDlCeEkyNzJRVjRpdnVSM3pSNjRGcVBSLWZR?oc=5</link><guid isPermaLink="false">CBMiVkFVX3lxTFB3LWRXZ2JuOW5DX1N5T0xUNnNKY3gzdDRIenFwRWV1cUUyQk5xclpKWnJZQVNHX1g0c2RKTDlCeEkyNzJRVjRpdnVSM3pSNjRGcVBSLWZR</guid><pubDate>Mon, 21 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTFB3LWRXZ2JuOW5DX1N5T0xUNnNKY3gzdDRIenFwRWV1cUUyQk5xclpKWnJZQVNHX1g0c2RKTDlCeEkyNzJRVjRpdnVSM3pSNjRGcVBSLWZR?oc=5" target="_blank"&gt;아스텔라스 이집트 사장에 이선희 한국아스텔라스 전무 임명&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;지디넷코리아&lt;/font&gt;</description><source url="https://zdnet.co.kr">지디넷코리아</source></item><item><title>한국아스텔라스 이선희 전무, 아스텔라스 이집트 사장으로 발탁 - 청년의사</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE5aeXVoSm9Gd2R2NXRhR1ZRaGF6cmFOQlc4NE9kZEl3OFF2eXFUdkRKNXVQbzNfamcxRW5hVTYtdFFWcUtfSjY0eno4dFBKendITEJCMUFESXloOUFlS2FKdVYyLUNyZVo1RnpLalV0b9IBc0FVX3lxTE1jT0lTbHYxREJQRmdwR0hpZzBlVUpqT1B1VDdNOVA4aTJoVnpxRnJScHhoWktiVjhiTGFIbXctT09aLTBpMjVaUFlFbnE1Q05zZi1XVVg2b3dYanhRUTRVYU9PelluY1lzeko5S0prRDg4Zkk?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE5aeXVoSm9Gd2R2NXRhR1ZRaGF6cmFOQlc4NE9kZEl3OFF2eXFUdkRKNXVQbzNfamcxRW5hVTYtdFFWcUtfSjY0eno4dFBKendITEJCMUFESXloOUFlS2FKdVYyLUNyZVo1RnpLalV0b9IBc0FVX3lxTE1jT0lTbHYxREJQRmdwR0hpZzBlVUpqT1B1VDdNOVA4aTJoVnpxRnJScHhoWktiVjhiTGFIbXctT09aLTBpMjVaUFlFbnE1Q05zZi1XVVg2b3dYanhRUTRVYU9PelluY1lzeko5S0prRDg4Zkk</guid><pubDate>Mon, 21 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE5aeXVoSm9Gd2R2NXRhR1ZRaGF6cmFOQlc4NE9kZEl3OFF2eXFUdkRKNXVQbzNfamcxRW5hVTYtdFFWcUtfSjY0eno4dFBKendITEJCMUFESXloOUFlS2FKdVYyLUNyZVo1RnpLalV0b9IBc0FVX3lxTE1jT0lTbHYxREJQRmdwR0hpZzBlVUpqT1B1VDdNOVA4aTJoVnpxRnJScHhoWktiVjhiTGFIbXctT09aLTBpMjVaUFlFbnE1Q05zZi1XVVg2b3dYanhRUTRVYU9PelluY1lzeko5S0prRDg4Zkk?oc=5" target="_blank"&gt;한국아스텔라스 이선희 전무, 아스텔라스 이집트 사장으로 발탁&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;청년의사&lt;/font&gt;</description><source url="http://www.docdocdoc.co.kr">청년의사</source></item><item><title>아스텔라스 위암 표적항암제 '빌로이', 급여 재도전 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTE91QXUyMlUtVFFYVHdoUG1zUWNjUkFYRU5xVDl4TzhZVHhxdHhMbmRNd3Fvc0s3TXdSQ2ZBX3h4Q2JCcHp6Tkt2eU5RUjkwNEkySlAyVU1sTDJpUnB5?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTE91QXUyMlUtVFFYVHdoUG1zUWNjUkFYRU5xVDl4TzhZVHhxdHhMbmRNd3Fvc0s3TXdSQ2ZBX3h4Q2JCcHp6Tkt2eU5RUjkwNEkySlAyVU1sTDJpUnB5</guid><pubDate>Thu, 10 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE91QXUyMlUtVFFYVHdoUG1zUWNjUkFYRU5xVDl4TzhZVHhxdHhMbmRNd3Fvc0s3TXdSQ2ZBX3h4Q2JCcHp6Tkt2eU5RUjkwNEkySlAyVU1sTDJpUnB5?oc=5" target="_blank"&gt;아스텔라스 위암 표적항암제 '빌로이', 급여 재도전&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://m.dailypharm.com">데일리팜</source></item><item><title>승진 가로막는 '폐경 낙인'…아스텔라스, 직장 인식 개선 캠페인 전세계 확대 - 약업신문</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTFBnWThQaVdQRHNTZndXdGcxXzVYRHBWMlloaDhhdkJ3UGtkRzNBbzgwOFpiV0VYVXNxNzBNdXhtV2tlaE9nRjVRTWZ4VEV4Ym45YnUzSWRmVGlibl96a1BGelY1Q2tmdw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTFBnWThQaVdQRHNTZndXdGcxXzVYRHBWMlloaDhhdkJ3UGtkRzNBbzgwOFpiV0VYVXNxNzBNdXhtV2tlaE9nRjVRTWZ4VEV4Ym45YnUzSWRmVGlibl96a1BGelY1Q2tmdw</guid><pubDate>Mon, 08 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTFBnWThQaVdQRHNTZndXdGcxXzVYRHBWMlloaDhhdkJ3UGtkRzNBbzgwOFpiV0VYVXNxNzBNdXhtV2tlaE9nRjVRTWZ4VEV4Ym45YnUzSWRmVGlibl96a1BGelY1Q2tmdw?oc=5" target="_blank"&gt;승진 가로막는 '폐경 낙인'…아스텔라스, 직장 인식 개선 캠페인 전세계 확대&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>아스텔라스·창업진흥원 MOU…국내 신약 개발 스타트업 지원 - 약업신문</title><link>https://news.google.com/rss/articles/CBMiywFBVV95cUxNY2lUMEtpSzVSRkdwRGhLeEZkRGN1SXVvN1llYjhqR0tTR3JCeFFraHlGYVoxZHpnVjYyeExlLUlOaTVWWktYRlRxVjBoSU1oWl9oLVNlQW80R3dYV19PUWd0MHZrclZXd1JaS3RxMTcyUVpLeHNVa2NJUkU0dGtwNTV0djZOc2FXUUpDSkw4VHMtNUZxd3lzeHUxT3lNM0RNWmItcnNNbVVobTBranF1dng5R0JjMlNOMUdsZk1MRjNCeGZrM0F2S1hRNA?oc=5</link><guid isPermaLink="false">CBMiywFBVV95cUxNY2lUMEtpSzVSRkdwRGhLeEZkRGN1SXVvN1llYjhqR0tTR3JCeFFraHlGYVoxZHpnVjYyeExlLUlOaTVWWktYRlRxVjBoSU1oWl9oLVNlQW80R3dYV19PUWd0MHZrclZXd1JaS3RxMTcyUVpLeHNVa2NJUkU0dGtwNTV0djZOc2FXUUpDSkw4VHMtNUZxd3lzeHUxT3lNM0RNWmItcnNNbVVobTBranF1dng5R0JjMlNOMUdsZk1MRjNCeGZrM0F2S1hRNA</guid><pubDate>Thu, 24 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxNY2lUMEtpSzVSRkdwRGhLeEZkRGN1SXVvN1llYjhqR0tTR3JCeFFraHlGYVoxZHpnVjYyeExlLUlOaTVWWktYRlRxVjBoSU1oWl9oLVNlQW80R3dYV19PUWd0MHZrclZXd1JaS3RxMTcyUVpLeHNVa2NJUkU0dGtwNTV0djZOc2FXUUpDSkw4VHMtNUZxd3lzeHUxT3lNM0RNWmItcnNNbVVobTBranF1dng5R0JjMlNOMUdsZk1MRjNCeGZrM0F2S1hRNA?oc=5" target="_blank"&gt;아스텔라스·창업진흥원 MOU…국내 신약 개발 스타트업 지원&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>한국아스텔라스 파드셉, 전이성 요로상피암 1차 병용요법 국내 허가 1주년 기념 기자간담회 개최 - 의사신문</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE1tX083MmN0YWpLRmVkbk5tZDh0UjZBRG4tUERXaDJ2QUowV3pJMUExczhpQjF3Skw5Y0ZtTm41dEJHYlZjSEJSd05yZ3NUWHNZWHlSVEx6UGdFTmdMRGVDZFJpbVRUSlBWMjRISWpJYw?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE1tX083MmN0YWpLRmVkbk5tZDh0UjZBRG4tUERXaDJ2QUowV3pJMUExczhpQjF3Skw5Y0ZtTm41dEJHYlZjSEJSd05yZ3NUWHNZWHlSVEx6UGdFTmdMRGVDZFJpbVRUSlBWMjRISWpJYw</guid><pubDate>Mon, 18 Aug 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1tX083MmN0YWpLRmVkbk5tZDh0UjZBRG4tUERXaDJ2QUowV3pJMUExczhpQjF3Skw5Y0ZtTm41dEJHYlZjSEJSd05yZ3NUWHNZWHlSVEx6UGdFTmdMRGVDZFJpbVRUSlBWMjRISWpJYw?oc=5" target="_blank"&gt;한국아스텔라스 파드셉, 전이성 요로상피암 1차 병용요법 국내 허가 1주년 기념 기자간담회 개최&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의사신문&lt;/font&gt;</description><source url="http://www.doctorstimes.com">의사신문</source></item><item><title>[Generic Trend]대원제약, '엑스탄디' 제네릭 시장 '조기 진입' 노린다 - PRESS9</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE82UjJfY1E3SFVHSzRWQUtWOUczWDlHa1lMdFlQaVlpcVJRRDNHRHVlODJZSlVwWXhYcVR3TzhUQnZyVkx6N3pXLUZydUJFOExnTXRuLW12cXVuRldaOXFYZUhwVUxmdw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE82UjJfY1E3SFVHSzRWQUtWOUczWDlHa1lMdFlQaVlpcVJRRDNHRHVlODJZSlVwWXhYcVR3TzhUQnZyVkx6N3pXLUZydUJFOExnTXRuLW12cXVuRldaOXFYZUhwVUxmdw</guid><pubDate>Wed, 24 Dec 2025 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE82UjJfY1E3SFVHSzRWQUtWOUczWDlHa1lMdFlQaVlpcVJRRDNHRHVlODJZSlVwWXhYcVR3TzhUQnZyVkx6N3pXLUZydUJFOExnTXRuLW12cXVuRldaOXFYZUhwVUxmdw?oc=5" target="_blank"&gt;[Generic Trend]대원제약, '엑스탄디' 제네릭 시장 '조기 진입' 노린다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PRESS9&lt;/font&gt;</description><source url="https://www.press9.kr">PRESS9</source></item><item><title>화이자·아스텔라스 "엑스탄디+류프로라이드, 사망 위험 40% 줄여" - 뉴스1</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTFAyUXU4eW5OR3BweUFGRHRqLXJfN2VReXl4ZlFIRHhfV3NxWG5RdjhzVFpoeGhGMHU4RW0zY05wOFo1MkpJa0NwdXkyYmtQZmk0Y3ZjTVZ4YV9Xdjh4MlFpQg?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTFAyUXU4eW5OR3BweUFGRHRqLXJfN2VReXl4ZlFIRHhfV3NxWG5RdjhzVFpoeGhGMHU4RW0zY05wOFo1MkpJa0NwdXkyYmtQZmk0Y3ZjTVZ4YV9Xdjh4MlFpQg</guid><pubDate>Mon, 20 Oct 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFAyUXU4eW5OR3BweUFGRHRqLXJfN2VReXl4ZlFIRHhfV3NxWG5RdjhzVFpoeGhGMHU4RW0zY05wOFo1MkpJa0NwdXkyYmtQZmk0Y3ZjTVZ4YV9Xdjh4MlFpQg?oc=5" target="_blank"&gt;화이자·아스텔라스 "엑스탄디+류프로라이드, 사망 위험 40% 줄여"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스1&lt;/font&gt;</description><source url="https://www.news1.kr">뉴스1</source></item><item><title>아스텔라스 '파드셉', 영국서 전이성 요로상피암 1차 병용요법 급여 승인 - 머니투데이 - 머니투데이</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE8wc1dSd3NZQ3JmUTJadGdWclNVRnlvbWFTRlh6Vm5OWnZOYV9pcjE0cGFZTEJ5cEF0aVlDcjk0ekpMYmJSZXdGdlNUc2taTld2Z0t5Nm1WajI2STBBcllZN19rbDhSQklDRkHSAW9BVV95cUxPaHBBTEJaaEY4WlZQQ2VFMVFKWlFMSzVCTkNTYThKb1c0WW5DbnZFSlRzYnpKVGJIdkd1cG44UnZJQWc3NGhVVExtclNOTnMyRkVTV0tlSHVfdmNyMHNHeFVfUkN6TGJObjQwcmFrZzg?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE8wc1dSd3NZQ3JmUTJadGdWclNVRnlvbWFTRlh6Vm5OWnZOYV9pcjE0cGFZTEJ5cEF0aVlDcjk0ekpMYmJSZXdGdlNUc2taTld2Z0t5Nm1WajI2STBBcllZN19rbDhSQklDRkHSAW9BVV95cUxPaHBBTEJaaEY4WlZQQ2VFMVFKWlFMSzVCTkNTYThKb1c0WW5DbnZFSlRzYnpKVGJIdkd1cG44UnZJQWc3NGhVVExtclNOTnMyRkVTV0tlSHVfdmNyMHNHeFVfUkN6TGJObjQwcmFrZzg</guid><pubDate>Fri, 05 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE8wc1dSd3NZQ3JmUTJadGdWclNVRnlvbWFTRlh6Vm5OWnZOYV9pcjE0cGFZTEJ5cEF0aVlDcjk0ekpMYmJSZXdGdlNUc2taTld2Z0t5Nm1WajI2STBBcllZN19rbDhSQklDRkHSAW9BVV95cUxPaHBBTEJaaEY4WlZQQ2VFMVFKWlFMSzVCTkNTYThKb1c0WW5DbnZFSlRzYnpKVGJIdkd1cG44UnZJQWc3NGhVVExtclNOTnMyRkVTV0tlSHVfdmNyMHNHeFVfUkN6TGJObjQwcmFrZzg?oc=5" target="_blank"&gt;아스텔라스 '파드셉', 영국서 전이성 요로상피암 1차 병용요법 급여 승인 - 머니투데이&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;머니투데이&lt;/font&gt;</description><source url="https://www.mt.co.kr">머니투데이</source></item><item><title>한국아스텔라스, 문수미 이사 등 해외지사 진출 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9Odkc2eFo3TVljRnhXRFVRdXA5WjI3bnpVelVGMTdBSWQzcVAxMm1hWXdGdXJYS2V0Wl83Tjh2cFZDZEFUWTZ4QWN1cHpzVGdpWFU1eEV4LVJjR2h5UFItUTdsUjZScmpEaHk1YQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9Odkc2eFo3TVljRnhXRFVRdXA5WjI3bnpVelVGMTdBSWQzcVAxMm1hWXdGdXJYS2V0Wl83Tjh2cFZDZEFUWTZ4QWN1cHpzVGdpWFU1eEV4LVJjR2h5UFItUTdsUjZScmpEaHk1YQ</guid><pubDate>Tue, 03 Dec 2024 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9Odkc2eFo3TVljRnhXRFVRdXA5WjI3bnpVelVGMTdBSWQzcVAxMm1hWXdGdXJYS2V0Wl83Tjh2cFZDZEFUWTZ4QWN1cHpzVGdpWFU1eEV4LVJjR2h5UFItUTdsUjZScmpEaHk1YQ?oc=5" target="_blank"&gt;한국아스텔라스, 문수미 이사 등 해외지사 진출&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>화이자·아스텔라스, '엑스탄디' 고위험 BCR 전립선암서 OS 이점…“적응증 확대 기대” - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE8yR2ZNeTBsTnExcjgwMkpGRG9UWUpLbkxGTGJFeTIwellNUXMxZTNNdXp5aFRDUXRjWDQ4OVZtcEJxaG1telFzbVBOVFZaLTlXeDBIQVdfX05XbEM1NGJaeWF3TFZUNU9HTkNOONIBcEFVX3lxTFB2WDdkd1psTUFfM1NWanZoaEZrdVlPdVFqSS03RkxaVnlURUw2Q0FzUGhyUkxSYWJtMG03THhQbmFqd0NySnp1NElLYWJGVmE5VHJZajRhUnFjRUpJV0xmNzMtSnFRVVZQQzRJQmlTRlQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE8yR2ZNeTBsTnExcjgwMkpGRG9UWUpLbkxGTGJFeTIwellNUXMxZTNNdXp5aFRDUXRjWDQ4OVZtcEJxaG1telFzbVBOVFZaLTlXeDBIQVdfX05XbEM1NGJaeWF3TFZUNU9HTkNOONIBcEFVX3lxTFB2WDdkd1psTUFfM1NWanZoaEZrdVlPdVFqSS03RkxaVnlURUw2Q0FzUGhyUkxSYWJtMG03THhQbmFqd0NySnp1NElLYWJGVmE5VHJZajRhUnFjRUpJV0xmNzMtSnFRVVZQQzRJQmlTRlQ</guid><pubDate>Fri, 11 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE8yR2ZNeTBsTnExcjgwMkpGRG9UWUpLbkxGTGJFeTIwellNUXMxZTNNdXp5aFRDUXRjWDQ4OVZtcEJxaG1telFzbVBOVFZaLTlXeDBIQVdfX05XbEM1NGJaeWF3TFZUNU9HTkNOONIBcEFVX3lxTFB2WDdkd1psTUFfM1NWanZoaEZrdVlPdVFqSS03RkxaVnlURUw2Q0FzUGhyUkxSYWJtMG03THhQbmFqd0NySnp1NElLYWJGVmE5VHJZajRhUnFjRUpJV0xmNzMtSnFRVVZQQzRJQmlTRlQ?oc=5" target="_blank"&gt;화이자·아스텔라스, '엑스탄디' 고위험 BCR 전립선암서 OS 이점…“적응증 확대 기대”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>[허가/임상] 퓨쳐켐, 전립선암 방사성 신약 후보 'FC705' 3상 승인 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5NWTN5LXVLSmJsS01kaTh0RXRHcTRlNHo0d0Ntc0ZvNXIzUFN4VTFPTlVjT2JqSW9BOHpTWlVBZnhhVGVkTFBwWWhpZ0lQbDd3ZG9mcFpqZEY4dmtMMzVjdDhyUzQ5bHJlYmp3?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5NWTN5LXVLSmJsS01kaTh0RXRHcTRlNHo0d0Ntc0ZvNXIzUFN4VTFPTlVjT2JqSW9BOHpTWlVBZnhhVGVkTFBwWWhpZ0lQbDd3ZG9mcFpqZEY4dmtMMzVjdDhyUzQ5bHJlYmp3</guid><pubDate>Mon, 08 Sep 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5NWTN5LXVLSmJsS01kaTh0RXRHcTRlNHo0d0Ntc0ZvNXIzUFN4VTFPTlVjT2JqSW9BOHpTWlVBZnhhVGVkTFBwWWhpZ0lQbDd3ZG9mcFpqZEY4dmtMMzVjdDhyUzQ5bHJlYmp3?oc=5" target="_blank"&gt;[허가/임상] 퓨쳐켐, 전립선암 방사성 신약 후보 'FC705' 3상 승인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>한국아스텔라스, 의학부 총괄에 강예림 박사 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBHdFFkMXBfdTNlZ1VaemViRUthS09ZSU1icmxCSWJPdkVqQmJIWGdRellNWUFvNVMwNnZ5eFRBRU5tZTZYbTliVXR3YzhfQTNzc2hKaDF6ZGVqcmxiOXRhb0NDNDhmOHd2Ni1r?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBHdFFkMXBfdTNlZ1VaemViRUthS09ZSU1icmxCSWJPdkVqQmJIWGdRellNWUFvNVMwNnZ5eFRBRU5tZTZYbTliVXR3YzhfQTNzc2hKaDF6ZGVqcmxiOXRhb0NDNDhmOHd2Ni1r</guid><pubDate>Wed, 07 May 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBHdFFkMXBfdTNlZ1VaemViRUthS09ZSU1icmxCSWJPdkVqQmJIWGdRellNWUFvNVMwNnZ5eFRBRU5tZTZYbTliVXR3YzhfQTNzc2hKaDF6ZGVqcmxiOXRhb0NDNDhmOHd2Ni1r?oc=5" target="_blank"&gt;한국아스텔라스, 의학부 총괄에 강예림 박사&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item></channel></rss>